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SUMMARY 
One of the key challenges in biotherapeutics production is the selection of a high-
producing animal cell line to maximize protein yield in cell culture. Clone selection is 
often a tedious process, involving rounds of selection and single cell cloning which is 
costly in both money and time. In an effort to increase the throughput of clone 
selection, we identified key signatures of a high producer cell using an integrated 
genomic and proteomic platform.  
In our study, a fluorescence activated cell sorter (FACS) was used to rapidly 
select and sort chinese hamster ovary (CHO) cells expressing different levels of a 
model recombinant fusion protein (dhfr-GFP), where green fluorescent protein (GFP) 
was tagged to dihydrofolate reductase (dhfr). Two populations stably expressing high 
and low levels of dhfr-GFP were subsequently selected and characterized, followed 
by comparative transcriptomic and proteomic analysis. Transcript levels in the mid-
exponential phase was compared using a proprietary 15k CHO cDNA microarray chip 
with 7559 unique elements, while protein levels in the mid-exponential and stationary 
phases were evaluated using the iTRAQ quantitative protein profiling technique. 
Although there was a general lack of correlation between mRNA levels and 
quantitated protein abundance, results from both datasets concurred on groups of 
proteins/genes based on functional categorization. 
From microarray analysis, 78 genes were differentially regulated (≥1.5-fold 
change and p-value <0.05) with significant numbers involved in protein metabolism 
(17%), transcription (9%) and cell cycle (9%). 41% of the genes have unknown 
functions, providing a potential source of discovery for novel genes. Proteomic 
analysis gave 20 and 26 proteins that satisfied the cut-off criteria (≥ 1.2-fold change, 
95% confidence) for the mid-exponential and stationary phase respectively. In the 
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mid-exponential phase, proteomics data concurred with microarray data with the 
largest number of regulated proteins in protein metabolism (35%), followed by 
transcription (15%) and cell cycle (15%). Proteins in the stationary phase, however, 
had protein metabolism (22%) and oxidative stress response (18%) as the two major 
groups, followed by carbohydrate metabolism (12%), cell cycle (12%), signal 
transduction (12%) and transcription (12%).  
Combined transcriptome and proteome analysis of the high producer thus 
revealed the following: (i) increased energy through the up regulation of carbohydrate 
and lipid metabolism, and increased abundance of mitochondria; (ii) decreased cell 
proliferation and reduced apoptosis; (iii) increased protein biosynthesis through the 
regulation of protein metabolism (protein foldases, translation factors and 
ubiquitylation enzymes), transcription (transcription factors, splicing factors, 
chromatin opening enzymes and histones) and cytoskeleton (actin and microtubules); 
and (iv) reduced stress response in ER and oxidative stress.  From our results, we did 
not detect any genes/proteins with drastic fold-changes. Instead, there were 
differential expressions of up to 3-fold in a wide array of genes/proteins involved in 
various cellular processes. Thus, the key to improving protein production involves the 
orchestration of several cellular processes and not the overexpression of a single or 
few genes. The balance and distribution of energy, together with increased activity in 
protein biosynthesis and the reduction of cellular stress, all play a part in high 
recombinant protein production. 
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1 INTRODUCTION 
1.1 Background 
1.1.1 Recombinant protein production 
The production of recombinant proteins using mammalian cells is a massive industry 
today, accounting for billions of dollars in bio-therapeutic products annually. 
Mammalian cell culture is the dominant system for recombinant protein production 
due to their capacity for proper protein folding, assembly and post-translational 
modification. Chinese hamster ovary (CHO) cells have become the host of choice, 
largely because they have been well characterized and there is a history of regulatory 
approval for recombinant proteins produced from these cells (Anderson and 
Krummen, 2002; Chu and Robinson, 2001). To meet market demands, the scale of 
bio-therapeutic production is usually very large, often in tens of thousands of litres, 
which is costly in both money and time. Consequently, maximizing yield in cell 
culture is essential if economic processes are to be established. Recently, the 
productivity of mammalian cells cultivated in bioreactors has reached gram per liter 
range (Birch, 2004; Crowley, 2004), a dramatic yield improvement of more than 100-
fold over titers seen for similar processes in the mid-1980s. This increased 
productivity resulted mainly from the optimization of media composition and process 
control. Thus, opportunities still exist for improving mammalian cell systems through 
advancements in production systems, as well as vector and host cell engineering 
(Wurm, 2004). 
1.1.2 Selection of high producing clones 
Stable transfection of CHO cells is the well-established system for the production of 
recombinant proteins in the industry today. An expression vector encoding the desired 
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gene of interest and a selective marker is first introduced into the cell, followed by the 
selection of transfected clones using a selective agent. The integration site of the 
transgene has a major effect on the transcription rate of the recombinant gene (a 
phenomenon known as the position effect). Integration into inactive heterochromatin 
results in little or no transgene expression, while integration into active euchromatin 
frequently allows transgene expression (Rincon-Arano and Recillas-Targa, 2004). 
Currently, the generation of a high producing cell line is a tedious process involving 
many rounds of selection and single cell cloning. Many hundreds, even thousands of 
transfected clones are typically screened for random variation in recombinant protein 
production and this process can span over weeks to months, depending on the stability 
of the cell line.  
Numerous strategies have been devised to enrich the populations of CHO 
producing high levels of recombinant proteins. Two of the most widely used methods 
are the amplification systems using dihydrofolate reductase (DHFR) (Alt et al, 1978) 
and glutamine synthetase (GS) (Cockett et al, 1990). Other methods include, 
modification of the DHFR amplification system where both selectable marker and 
recombinant cDNA are expressed from a single primary transcript at a fixed ratio via 
differential splicing to increase recombinant protein production (Lucas et al, 1996), 
cell surface labeling technique using fluorescently tagged antibodies and fluorescence 
intensity to enrich populations of highly productive cells using preparative flow 
cytometry sorting (Brezinsky et al, 2003), and the mutation of the neomycin selection 
marker so as to enhance the population of high producers (Sautter and Enenkel, 2005). 
1.2 Project scope 
Despite the dramatic success in improving the yields of recombinant protein 
production, the biological traits that confer high productivity in a cell remain vague. 
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In an effort to increase throughput of clone selection, we seek to understand the 
biology of high producers at a molecular level using high throughput technologies 
such as an integrated genomic and proteomic platform. In this study, we characterized 
two populations of cells expressing varying amounts of a model recombinant protein 
and identified differences between them.  
1.2.1 Rapid selection of high producing clones based on GFP 
screening 
Before we could carry out any analysis, we had to create stable cell lines expressing 
various levels of recombinant protein. To enable rapid screening and selection of 
CHO clones expressing various levels of recombinant protein, we tagged a green 
fluorescent protein (GFP) to dihydrofolate reductase (DHFR) and sorted cells 
according to their fluorescence using FACS analysis. Cells with high fluorescence 
intensity corresponded to a high levels of recombinant protein and vice versa. To 
ensure the long-term expression of the recombinant gene, the stability of cells was 
monitored using their FACS profiles and two stable clones producing high and low 
levels of DHFR-GFP fusion protein were ultimately selected. These clones were 
cultured and their growth kinetics monitored before transcriptomic and proteomic 
analysis. 
1.2.2 Combined transcriptomic and proteomic analysis to reveal the 
biology of high producers 
Since it is highly plausible that the gene and protein expression profile of a highly 
productive cell line holds the key signature for high productivity, we used combined 
transcriptome and proteome profile analysis to gain insight to the changes occurring 
in a cell as a result of recombinant protein expression. Microarray and iTRAQ protein 
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quantification technique were used to obtain and analyze the global expression 
patterns of a wide range of genes/proteins involved in transcription, protein 
synthesis/degradation, cell cycle, apoptosis, metabolism and signal transduction. 
These data characterize the cell machinery in a high producer and provide potential 
targets for the creation of a better host cell line. In addition, these findings are also 
valuable in a rational approach to the design of media and cell culture parameters 
leading to enhanced productivity in CHO cells. 
In this study, proteomics profiling was done in collaboration with the 
proteomics laboratory under the guidance of Robin and Yee Jiun. 
1.2.3 Thesis organization 
The literature review (Chapter 2) starts with an overview of the current methods used 
to improve recombinant protein production in mammalian cell culture, followed by 
the use of GFP (green fluorescent protein), and the methods used in transcriptome and 
proteome profiling.  
Chapter 3 describes the material and methods for the construction of the 
screening vector, cell culture and the microarray and proteomics technology used in 
this project. 
Chapter 4 presents results obtained from the comparative microarray and 
proteomic analysis between the high and low producers. 
Chapter 5 discusses the results obtained, followed by the key signature of the 
high producer, and the recommendations for a high throughput approach in the 
screening for a high producing cell line. 
This thesis concludes with a summary of our key findings, and recommends 
some areas for improvement and future studies. 
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2 LITERATURE REVIEW 
2.1 Improving productivity in mammalian cell culture 
2.1.1 Host cell engineering 
One of the most notable advances in recent years has been the application of genetic 
engineering approaches to rationally modify specific features of mammalian host cells 
to improve their efficacy in recombinant protein expression. These include, enhancing 
cell viability in culture, controlling cell growth, and improvements in protein 
processing.  
In order to extend cell viability in culture, gene engineering has been applied 
to cell death pathways, where anti-apoptotic genes such as Bcl-2 and Bcl-XL are 
overexpressed in cells to inhibit apoptosis at distinct points along the apoptotic 
pathways (Laken and Leonard, 2001; Mastrangelo et al, 2000). Though promising, the 
effects observed in these studies have been variable depending on the cell line and the 
culture conditions. This is because apoptosis occurs through many different regulatory 
pathways and targeting a specific path may not be sufficient to achieve significant 
benefits. In addition, a study by Figueroa et al (2001) found wild-type Bcl-2 to be 
susceptible to intracellular degradation when they compared the overexpression of 
Bcl-2 to a Bcl-2 deletion mutant in chinese hamster ovary (CHO) and baby hamster 
kidney (BHK) cells. This may also explain some of the limited effects on productivity 
that have been reported for Bcl-2-based strategies (Laken and Leonard, 2001). With 
regards to protein production, this method is most effective when cell survival limits 
productivity. In short-term batch cultures, the expression of anti-apoptosis genes may 
not be particularly advantageous because viabilities remain high throughout the cell 
culture. However, in extended fed-batch and perfusion cell-culture experiments, the 
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increase in viabilities might be significant for mammalian cells engineered to express 
anti-apoptosis genes (Arden and Betenbaugh, 2004a). 
In a modified approach, proto-oncogenes, cell cycle control genes and growth 
factor genes, in addition to anti-apoptotic genes, have been inserted into cells to 
generate host cell lines that are able to proliferate and survive in high density cultures 
prevalent in large scale bioreactors (Arden et al, 2004b). Conversely, there have been 
attempts to arrest cell growth while limiting apoptotic cell death based on the 
phenomenon of inverse growth-associated production (Fussenegger et al, 1998; 
Mazur et al, 1998). In these studies, growth arrest is associated with as much as a 15-
fold increase in specific productivity. 
The improvement in post-translational protein modification and processing is 
another noteworthy development. In the area of glycosylation control, the 
overexpression of appropriate glycosyltransferases not normally present in the host 
cells can enhance the glycan quality of the recombinant protein. For example, the 
overexpression of a galactosyltransferase and a sialyltransferase in CHO cells led to 
corresponding increases in the galactose and sialic acid content of expressed 
recombinant therapeutic proteins (Weikert et al, 1999) while stable overexpression of 
N-acetylglucosaminyltransferase III increased the fraction of bisecting N-
acetylglucosamine residues on antibodies produced in CHO cells (Umana et el, 1999). 
2.1.2 Generation of stable high producing cell lines 
2.1.2.1 DNA delivery and integration 
The establishment of a recombinant cell line begins with the introduction of a 
linearized expression vector containing the transgene and a selectable marker into the 
host cell. Upon integration of DNA into the host genome, transformants are selected 
based on their selectable markers in the appropriate media. This is the method of 
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choice for most manufacturing processes today in the creation of a stable recombinant 
cell line (Wurm, 2004).  
As linearized DNA is randomly integrated into the host genome, efficient 
expression of the transgene is highly dependant on the site of integration (position 
effect). In addition, transgene expression in mammalian cells is rapidly inactivated at 
the level of chromatin due to epigenetic gene silencing (Rincon-Arano and Recillas-
Targa, 2004; Qin et al, 2003; Matzke et al, 2000). In order to circumvent this problem, 
several strategies have emerged during recent years with the aim of enhancing and 
stabilizing transgene expression. These include, adding reagents to promote histone 
acetylation, the addition of cis-acting DNA elements (such as insulators, ubiquitous 
chromatin opening elements, matrix associated regions and antirepressor elements) to 
the transgene expression vector to prevent gene silencing, and targeting transgenes to 
genomic sites that are favorable for gene expression (Kwaks and Otte, 2006). At this 
point in time however, little is known about the molecular mechanisms underlying 
any of the DNA elements mentioned and these elements seem to be operationally 
defined – either they work, or they do not work at all. More information is required to 
understand why and how epigenetic gene-regulatory elements are beneficial for 
recombinant protein expression before this system can be applied widely in the 
industry. 
2.1.2.2 Selection of high producers 
After transformants have been selected, the search for a stable high producing cell line 
begins with the laborious and time consuming task of clone selection. As discussed 
previously, this is due to the poor frequency of stable transformants, coupled with 
most clones showing low levels of recombinant protein production during cell 
cultivation. Thus, the initial stages of screening involves the maintenance of hundreds 
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and thousands of clones, as it is often difficult to know which clone will exhibit both 
stable and high expression of the desired product over long periods of time. The 
difference in the specific productivity of the initial cell pool after transfection and the 
final stable producing clone may be as much as two orders of magnitude, which 
makes this screening process crucial for recombinant protein production in the 
industry (Korke et al, 2002). In order to enhance the number of high producing clones, 
several methods have been devised based on different strategies.   
(a) Gene amplification 
Gene amplification is used widely in the pharmaceutical industry today due to its 
accessibility and wide-ranging applicability. To date, the two most popular systems 
for CHO cells utilize dihydrofolate reductase (DHFR) and glutamine synthetase (GS) 
as the amplification markers (Wurm, 2004).   
In DHFR-mediated gene amplification, the presence of methotrexate (MTX) 
forces the cell to generate more copy numbers of the DHFR gene, resulting in the co-
amplification of the transgene, and hence an increase in recombinant protein 
expression. Despite its popularity, this system has its drawbacks. First, highly 
productive gene-amplified cell pools can only be obtained with a gradual step-wise 
increase in MTX (Yoshikawa et al, 2000a,b). In addition, cells become very 
heterogeneous during amplification, showing specific productivity variations of up to 
20-fold even though they were amplified from the same parental cell clone (Kim et al, 
1998). Thus, the best producers need to be isolated and amplified separately at each 
step. Coupled with a 4-step increment of MTX concentration, the entire process of 
obtaining a highly productive clone requires at least 6 months for completion 
(Yoshikawa et al, 2001). In 2005, Jun et al attempted a selection based on cell pools 
where the best producers were isolated only once at the final amplified stage. Though 
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less tedious, productivity was less than a third of that using the conventional method. 
Second, MTX promotes cytogenetic heterogeneity, an undesirable feature especially 
with respect to the regulatory process in the approval of the host cell line (Wurm, 
2004). The removal of MTX however, would entail additional screening for stable 
producers as most clones show a decline in specific productivity, with different rates, 
in the absence of selective pressure (Kim et al, 1998). Last, since DHFR is a non-
dominant marker, this selection is only readily applicable to DHFR-deficient CHO 
cell lines (Subramani et al, 1981). 
In GS-mediated gene amplification, CHO cells containing the transfected GS 
gene develop resistance to methionine sulfoximine (MSX), which results in the 
amplification of the GS gene and the accompanying transgene. Unlike the DHFR-
mediated gene amplification system, this system is applicable to CHO cells 
possessing an active endogenous GS gene and a single round of amplification is 
sufficient to achieve efficient expression of the recombinant product, taking typically 
around 3 months (Jun et al, 2006). Moreover, since GS catalyzes the synthesis of 
glutamine from glutamate and ammonia, the GS system offers a two-fold advantage 
of reducing ammonia levels in the culture media and providing glutamine to cells 
(Wurm, 2004).  
Despite these merits, GS-mediated gene amplification has not been widely 
used, as there were very few previous reports on the cultivation process of CHO cells 
with GS-mediated gene amplification (Brown et al, 1992; Hassell et al, 1992). 
Recently, a study by Jun et al (2006) showed there was no positive relationship 
observed between specific productivity and MSX concentration. In addition, highly 
amplified CHO-GS cells lose their productivity during long-term culture even in the 
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presence of MSX selective pressure. In this aspect, CHO-DHFR cells producing the 
same product showed great stability in the presence of MTX (Kim et al, 2001). 
(b) Reducing activity of selection markers 
In this strategy, the activity of the selection marker is reduced to allow stringent 
selection of high producers. Although the total number of clones is reduced after 
selection, the cells that survive tend to yield more recombinant product. 
Lucas et al (1996) used a dicistronic DHFR intron expression system where 
approximately 95% of the mRNA transcripts were spliced to encode only the 
transgene, while the remaining 5% were translated to produce DHFR for stable 
selection. Up to a 13-fold improvement of protein production was achieved in 
selective media even before gene amplification.  
In another approach, Sautter and Enenkel (2005) introduced mutations into the 
resistance marker gene, neomycin-phosphotransferase (NPT), to reduce its enzyme 
activity. This increases the proportion of high producers in a transfected cell 
population as the enzymatic impaired NPT must be compensated by a higher 
expression level in order for cells to survive under selective pressure.   
(c) High throughput cell sorting 
The establishment of flow cytometry technology has enabled high throughput 
screening and cell sorting in recent years, especially in the area of fluorescence 
activated cell sorting (FACS).  
Brezinsky et al (2003) have nicely illustrated in their work how cell sorting 
can efficiently sort for high producers. Cell surface labeling technique using 
fluorescently tagged antibodies was applied to enable FACS for high producing 
recombinant CHO cells, where high fluorescence intensity corresponds to high 
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recombinant protein production. Using FACS, the proportion of high producers was 
greatly increased, as non- or low-producing cells were eliminated. The timeline for 
sorting was 6–12 weeks, compared to at least 6 months using limiting dilution, to 
achieve similar production levels.  
Other studies have also utilized FACS with different fluorescent markers. 
Yoshikawa et al (2001) used a fluorescein isothiocyanate-labeled methotrexate (F-
MTX) reagent to distinguish highly productive gene-amplified cells, while Meng et al 
(2000) expressed the intracellular GFP and used it as a second selectable marker, 
other than DHFR, for the selection of high producing clones from transfected CHO 
cells.   
2.1.3 Transient gene expression 
In transient transfection, the expression vector is introduced to the host cells in its 
non-linearized form. Most of the introduced DNA is maintained in the nucleus in an 
extrachromosomal state (episomal DNA), and persists for just a short time before it is 
diluted and degraded. Thus, the properties of the cell are changed by the introduced 
transgene only for a short duration (Primrose, 2002). 
Recent advancements in large-scale transient transfection approaches have 
made this process an attractive option for recombinant protein production in the early 
stages of clinical testing. As opposed to the development of stable cell clones, this 
approach is rapid, cost effective and allows the expression of very different proteins 
with a single protocol (Baldi et al, 2005; Geisse and Henke, 2005).  
Large scale transient gene expression using polyethylenimine (PEI)-mediated 
transfection has been successfully applied to CHO cells (Derouazi et al, 2004), 
yielding expression levels of 10mg/L for an intracellular protein and 8mg/L for a 
secreted antibody in a 20L bioreactor. Using the same system, Galbraith et al (2006) 
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showed that the efficiency of transient production processes (recombinant protein 
output per recombinant DNA input) can be significantly improved using a 
combination of mild hypothermia and growth factor(s) to yield antibody titers of 39 
mg/L. In a different approach, Kunaparaju et al (2005) developed a transient 
expression system for CHO cells based on the autonomous replication and retention 
of episomal DNA in dividing cells. The presence of more plasmid copies that persist 
in the transfected cell throughout the production phase leads to a prolonged and 
improved recombinant production. Using this approach, transfected CHO cells were 
able to produce 75 mg/L of human growth hormone (hGH) in culture supernatants 11 
days following transfection. 
Beyond recombinant protein production, transient transfection can also be 
applied in host cell engineering. Underhill et al (2003) observed a 3-fold increase in 
luciferase reporter activity in CHO cells when they transiently expressed a non-
phosphorylatable eIF2α mutant to increase mRNA translation initiation activity. Thus, 
this work demonstrated the basis for an approach that generically up-regulates the 
transient expression of recombinant proteins by simultaneous host cell engineering. 
2.1.4 Media and process variables 
The culture medium provides the essential nutrients and energy source for the cell to 
maintain its growth and cellular functions. In the past, the addition of fetal bovine 
serum (FBS) was essential for cell propagation. However, recent demands on 
economy, reproducibility and regulatory concerns have led to the development of 
serum-free, chemically defined cell culture media. Many commercially available 
basal media are based on compositions established in serum-containing formats, but 
most cell lines can be cultured efficiently in these newer formulations (Wurm 2004). 
Supplementation is often required to provide components that are too labile to include 
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in the basal media, that are application- or cell line- specific, or that are vector 
determined selective agents (Whitford, 2005). Other additives have also been added to 
improve recombinant protein productivity, for example, sodium butyrate to increase 
transcription (Sung and Lee, 2005; Hunt et al, 2002), antioxidants to reduce apoptosis 
(Yun et al, 2001), and in the case for glycosylated proteins, nucleotide-sugar 
precursors to improve N-glycan processing (Baker et al, 2001). 
Process development has to be tailored for each individual recombinant cell 
line as clonal derivatives often display their own metabolic characteristics. Amongst 
the various process modes available for bioproduction, the fed-batch approach has 
gained popularity in large-scale cultures, due to its ease of operation and flexibility 
(Whitford, 2006). Optimization of a fed-batch process involves variables such as feed 
solution constituents and concentrations, the timing and duration of feed introduction, 
and the control of reactor operating parameters (Lavric et al, 2005; Wong et al, 2005). 
To reduce cost and labor, process optimizations are usually carried out in scaled down 
systems that mimic conditions in a full-scale bioreactor. Small bioreactors with 
operating volumes of 1 to 2 litres are currently most popular (Wurm, 2004), and a 
shaken 50ml conical centrifuge tube with a ventilated cap was recently developed, 
showing reactor like growth and productivity performance  (De Jesus et al, 2004). 
Newer technologies promise to shorten development timelines even further. For 
instance, SimCell reactors from BioProcessors are miniaturized bioreactors that are 
able to operate and independently control up to 1500 cultures, thus allowing the use of 
full factorial experimental design methods for process optimization (Stokelman et al, 
2005). Moreover, new developments in online and real-time monitoring of nutrients, 
products and metabolic waste will contribute to the speed and efficiency in which 
feed composition and timing are developed (Allston-Griffin, 2005). 
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2.2 Green fluorescent protein 
Green fluorescent protein (GFP), a bioluminescent marker cloned from the jellyfish 
Aequoria victoria, causes cells to emit bright green fluorescence when exposed to 
blue or ultraviolet light (Ward, 1979). Unlike luciferase, GFP has no substrate 
requirements and can therefore be used as a reporter marker to assay cellular 
processes in real-time. Other advantages of the molecule include, its non-toxicity, its 
non-interference with normal cellular activity and its stability even under harsh 
conditions (Ward, 1998). 
GFP is particularly useful for generating fusion proteins, providing a tag to 
localize recombinant proteins in the cell. This facilitates the investigation of 
intracellular protein trafficking and even the transport of proteins between cells 
(Viallet and Vo-Dinh, 2003; Kohler et al, 1997). In studies on recombinant protein 
production, GFP has been successfully applied as a reporter gene to evaluate culture 
conditions (Pham et al, 2005; Hunt et al, 2002; Kang et al, 2001), as well as a 
selectable marker to facilitate FACS analysis for high producing cells (Bailey et al, 
2002; Yuk et al, 2002; Meng et al, 2000). 
 
2.3 Transcriptomics and proteomics  
2.3.1 High throughput technology 
The advent of high throughput genomic and proteomic technologies has 
revolutionized the way in which gene and protein expression are analyzed today. 
Microarray allows the simultaneous quantification of thousands of mRNA transcripts 
in a miniaturized, automated format; making it possible to investigate changes in gene 
expression on a global scale. Similarly, recent advances in liquid chromatography-
Chapter 2  Literature review 
  15 
mass spectrometric (LC-MS) and protein labeling techniques have allowed the rapid 
identification and accurate quantification of differentially regulated proteins, enabling 
researchers to profile the overall changes in cellular proteins. 
2.3.1.3 cDNA microarray 
In cDNA microarray, “probes” of PCR amplified cDNA fragments (ESTs) are arrayed 
onto microscope slides, while “targets” are labeled cDNA generated from cells or 
tissue samples whose gene expression is to be studied (Schena et al, 1995). In 
comparative transcription profiling (e.g. control vs. treated samples), each population 
of targets is separately labeled with fluorescent dyes that have non-overlapping 
emission spectra before hybridization to the array. The fluorescence signal intensity 
observed on the probe is assumed to be proportional to the amount of transcript 
present. Hence, by measuring the intensity ratios, the differential gene expression of 
two samples can be obtained (Figure 2.1). 
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2.3.1.4 iTRAQ reagents 
LC-MS has been used for the identification of proteins from complexes and cell 
lysates (qualitative proteomics), and until recently the quantitative study of gene 
expression using differential display has been restricted to two-dimensional (2D) gel 
analyses (Korke et al, 2002). The development of isotope coded affinity tags (ICAT) 
lead to an alternative non-gel based approach for the quantitative study of differential 
protein regulation (Gygi et al, 1999a) and in 2004, an improved approach analogous 
to ICAT was developed using iTRAQ reagents (Applied Biosystems). 
The iTRAQ reagents are a set of four isobaric reagents (114, 115, 116 and 117) 
that are amine specific and thus tag all peptides, thereby expanding proteome 
coverage while retaining important post-translational modification information. In 
addition, they allow multiplex analysis of up to four samples in a single run with 
absolute quantification. The procedure first involves the iTRAQ labeling of peptides 
generated from protein digests that have been isolated from cell samples. The labeled 
samples are then combined, fractionated and analyzed by tandem mass spectrometry 
(Figure 2.2). Fragmentation data from peptides results in the identification of the 
labeled peptides through database searching, and hence the identification of 
corresponding proteins. On the other hand, fragmentation of the iTRAQ label 
generates a low molecular mass reporter ion that is unique to the tag used to label 
each sample. By measuring the intensity of these reporter ions, the relative quantity of 
each peptide from each sample can be determined (Figure 2.3). 
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2.3.2 Applications 
Both genomic and proteomic profiling have found wide applications in the fields of 
disease and drug discovery research, especially in the identification of cancer 
biomarkers (Alaoui-Jamali and Xu, 2006; Zieske, 2006; Butte, 2002; Heller, 2002). 
Typically, the resulting microarray or proteomic data will highlight a small group of 
differentially expressed genes or proteins as potential biomarkers for further 
examination. Alternatively, transcription profiling can be used to identify fingerprints 
that are predictive of disease outcomes (Yeoh et al, 2002) 
In bioprocessing, cDNA microarrays have been applied to investigate changes 
in gene expression when cells undergo adaptation, changes in other process conditions 
or environmental perturbations. For example, Iyer et al (1999) examined the changes 
in gene expression of fibroblasts in culture in response to changes in serum 
concentration, while Wong et al (2006) monitored the global expression profile of 
hybridomas in insulin and zinc-supplemented cultures to determine the effect of zinc 
as an insulin replacement. The relatively new technique of iTRAQ has not gained 
wide usage, but other proteomic tools have been used extensively for product 
characterization in the cell culture industry (Taverna et al, 1998), as well as the 
assessment of protein expression in cells as a consequence of changes in cell culture 
conditions. Using 2D gel electrophoresis, Lee et al (1996) identified proteins 
potentially involved in growth factor signaling by analyzing the protein expression 
patterns of CHO cells stimulated to grow by fetal calf serum, insulin, or basic 
fibroblast growth factor. In another study, Seow et al (2001) used the same approach 
to investigate the differential protein expression caused by a metabolic shift in 
mammalian cell culture and successfully identified metabolic enzymes, as well as 
isolating a novel protein. 
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So far, most studies have focused on the specific changes in cells occurring as 
a consequence of specific changes in culture conditions. No studies were found to 
target the transcriptome and proteome profiles of cell lines with different production 
capacities, thus leaving the biology of high producers largely unknown. 
2.3.3 Integrating transcriptomics and proteomics 
Due to the complexities in cellular biological processes, separate analysis of gene and 
protein expression only gives a partial glimpse into the entire cellular network. By 
combining genomics and proteomics analysis, a more comprehensive view on cellular 
mechanisms can be obtained, as exemplified by Korke et al (2002) in their analysis of 
metabolic shift in mammalian cell cultures, and Baik et al (2006) on the effect of low 
temperature induced expression in CHO cells producing erythropoietin. As shown in 
both studies, the strength of integrated genomic and proteomic techniques lies in the 
identification of novel genes or proteins that seem uninvolved in the phenomena 
under investigation, or identify post-transcriptional regulation. These new insights 
lead to a better understanding of the regulation of cellular events with bioprocess 
importance, and hence open up additional avenues for development. 
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3 MATERIALS AND METHODS 
3.1 Construction of screening vector pSV2-dhfr-GFP 
Mouse dihydrofolate reductase gene, dhfr, was amplified from plasmid pSV2-dhfr 
(ATCC 37146) using the forward primer 5’-TCGGCCTCTGAGCTATTCC-3’ and 
reverse primer 5’-CGACCGGTTCTTTCTTCTC-3’. The forward primer includes a 
HindIII site at the 5’ end of dhfr while the reverse primer removes the stop codon 
from dhfr and introduces an AgeI site (Figure 3.1 and Figure 3.2). 
Figure 3.1: Vector map of pSV2-dhfr. 
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Figure 3.2: Sequence of dhfr amplified from pSV2-dhfr. The dhfr open reading frame 
is highlighted, primer regions are indicated in bold and restriction sites HindIII 
(AAGCTT) and AgeI (ACCGGT) are underlined. 
 
GFP was amplified from pEGFP-1 (Clontech Laboratories) using the forward 
primer 5’-GCTCAAGCTTCGAATTCTGC-3’ and reverse primer 5’-AGATCTG 
GCCGCTTTACTTG-3’. The forward primer includes an AgeI site at the 5’ end of 
GFP while the reverse primer introduces a BglII site (Figure 3.3 and Figure 3.4).  
Figure 3.3: Vector map of pEGFP-1 
GCCGCCTCGG CCTCTGAGCT ATTCCAGAAG TAGTGAGGAG GCTTTTTTGG 
AGGCCTAGGC TTTTGCAAAA AGCTTTATCC CCGCTGCCAT CATGGTTCGA 
CCATTGAACT GCATCGTCGC CGTGTCCCAA GATATGGGGA TTGGCAAGAA 
CGGAGACCTA CCCTGGCCTC CGCTCAGGAA CGAGTTCAAG TACTTCCAAA 
GAATGACCAC AACCTCTTCA GTGGAAGGTA AACAGAATCT GGTGATTATG 
GGTAGGAAAA CCTGGTTCTC CATTCCTGAG AAGAATCGAC CTTTAAAGGA 
CAGAATTAAT ATAGTTCTCA GTAGAGAACT CAAAGAACCA CCACGAGGAG 
CTCATTTTCT TGCCAAAAGT TTGGATGATG CCTTAAGACT TATTGAACAA 
CCGGAATTGG CAAGTAAAGT AGACATGGTT TGGATAGTCG GAGGCAGTTC 
TGTTTACCAG GAAGCCATGA ATCAACCAGG CCACCTCAGA CTCTTTGTGA 
CAAGGATCAT GCAGGAATTT GAAAGTGACA CGTTTTTCCC AGAAATTGAT 
TTGGGGAAAT ATAAACTTCT CCCAGAATAC CCAGGCGTCC TCTCTGAGGT 
CCAGGAGGAA AAAGGCATCA AGTATAAGTT TGAAGTCTAC GAGAAGAAAG 
AACCGGTCG 
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Figure 3.4: GFP sequence amplified from pEGFP-1. GFP open reading frame is 
highlighted, primer regions are indicated in bold and restriction sites AgeI (AAGCTT) 
and BglII (AGATCT) are underlined. 
 
Both dhfr and GFP fragments were amplified by the polymerase chain 
reaction (PCR). Table 3.1 lists the reagents and conditions used. Taq polymerase, 
PCR buffer, MgCl2 solution and dNTPs were purchased from Promega. Primers were 
synthesized by Proligo and diluted to 10µM with double distilled water (ddH2O; 
Milli-Q, Millipore) before use. Reagents were mixed thoroughly in a 0.2ml thin-





 PCR reaction mix  PCR conditions  
       
 Reagents Vol (ul)  Temperature (oC) Time  
 ddH2O 16.2  95 5 min  
 10x PCR buffer 2.5  95 45 s  
 25mM MgCl2 3.0  55 45 s  
 10mM dNTPs 1.0  72 1 min  
 Forward Primer 0.5  72 10 min  
 Reverse Primer 0.5  4 ∞  
 Taq Polymerase 0.3     
 Vector Template 1.0     
 Total Volume 25.0     
       
Table 3.1: Reagents and conditions used in PCR for amplifying dhfr and GFP. 
CTAGCGCTCA AGCTTCGAAT TCTGCAGTCG ACGGTACCGC GGGCCCGGGA 
TCCACCGGTC GCCACCATGG TGAGCAAGGG CGAGGAGCTG TTCACCGGGG 
TGGTGCCCAT CCTGGTCGAG CTGGACGGCG ACGTAAACGG CCACAAGTTC 
AGCGTGTCCG GCGAGGGCGA GGGCGATGCC ACCTACGGCA AGCTGACCCT 
GAAGTTCATC TGCACCACCG GCAAGCTGCC CGTGCCCTGG CCCACCCTCG 
TGACCACCCT GACCTACGGC GTGCAGTGCT TCAGCCGCTA CCCCGACCAC 
ATGAAGCAGC ACGACTTCTT CAAGTCCGCC ATGCCCGAAG GCTACGTCCA 
GGAGCGCACC ATCTTCTTCA AGGACGACGG CAACTACAAG ACCCGCGCCG 
AGGTGAAGTT CGAGGGCGAC ACCCTGGTGA ACCGCATCGA GCTGAAGGGC 
ATCGACTTCA AGGAGGACGG CAACATCCTG GGGCACAAGC TGGAGTACAA 
CTACAACAGC CACAACGTCT ATATCATGGC CGACAAGCAG AAGAACGGCA 
TCAAGGTGAA CTTCAAGATC CGCCACAACA TCGAGGACGG CAGCGTGCAG 
CTCGCCGACC ACTACCAGCA GAACACCCCC ATCGGCGACG GCCCCGTGCT 
GCTGCCCGAC AACCACTACC TGAGCACCCA GTCCGCCCTG AGCAAAGACC 
CCAACGAGAA GCGCGATCAC ATGGTCCTGC TGGAGTTCGT GACCGCCGCC 
GGGATCACTC TCGGCATGGA CGAGCTGTAC AAGTAAAGCG GCCAGATCT 
30 cycles 
Chapter 3  Materials and methods 
  23 
The PCR fragments were subsequently resolved by agarose gel electrophoresis 
and purified using QIAquick Gel Extraction kit (Qiagen) according to manufacturer’s 
protocol. 
The purified PCR products, dhfr and GFP, were inserted into a pCR-TOPO2.1 
vector separately using the TOPO-TA Cloning kit (Invitrogen) according to 
manufacturer’s protocol to obtain TOPO-dhfr and TOPO-GFP. Following that, dhfr 
was inserted into HindIII and AgeI sites of TOPO-GFP to give TOPO-dhfr-GFP. 
Finally, the screening vector pSV2-dhfr-GFP was obtained by cloning dhfr-GFP into 
HindIII and BglII sites of pSV2-dhfr (Figure 3.5). All enzymes used in cloning were 
from Promega and were carried out according to the manufacturer’s protocol. DH5α 
E.coli cells were transformed to generate ligated plasmids except in TOPO-TA 
cloning, where TOP10 E.coli cells were used. All plasmid isolations were performed 
using Promega SV miniprep kits. Figure 3.6 gives a summary of the workflow for the 
construction of the screening vector pSV2-dhfr-GFP. 
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3.2 Cell culture 
3.2.1 Cell line 
CHO/dhfr- cells (ATCC CRL- 9096) were grown in T-flasks (TPP) containing 
Dulbecco’s Modified Eagle Medium (DMEM; Gibco) supplemented with 10% fetal 
bovine serum (FBS; HyClone), 100µM hypoxanthine and 16µM thymidine (HT; 
SIGMA-Aldrich). For maintenance, cells were passaged twice each week with a 
subcultivation ratio of 1:10. Cell cultures were maintained in a humidified 5% CO2 
environment at 37oC. 
3.2.2 Transfection 
The plasmid, pSV2-dhfr-GFP was linearized by digesting with EcoRI, purified by 
ethanol precipitation and resuspended in sterile ddH2O. CHO/dhfr- cells were 
transfected with 2µg of linearised pSV2-dhfr-GFP mixed with 6µl of FuGENE 6 
transfection reagent (Roche) in 6-well plates (Nunc) according to the manufacturer’s 
protocol. After transfection, cells were grown for 2 days in non-selective media 
(DMEM, 10% FBS, supplemented with HT) to allow the expression of dhfr-GFP. 
These cells were then harvested and seeded into T-flasks containing selective media 
(DMEM, 10% FBS). Cells were grown for 2 weeks before cell sorting by FACS 
(Fluorescence Activated Cell Sorting). These transfected cells were designated as 
CHO/dhfr-GFP. 
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3.2.3 FACS analysis and cell sorting 
To isolate clones expressing high and low levels of GFP, cells were scanned by FACS 
Vantage SE (Becton-Dickinson) and subsequently sorted as single cell into 96-well 
plates (Nunc). Sorting of cells was based on their fluorescence, as shown in the FACS 
profile of the transfected population in Figure 3.7. Two plates each of high 
fluorescing and low fluorescing cells were sorted.  
Figure 3.7: FACS profile of non-transfected (CHO/dhfr-) and transfected (CHO-dhfr-
GFP) cells. Single cell sorting was performed based on their fluorescence as indicated 
on the profile for CHO-dhfr-GFP. 
 
3.2.4 Single cell cultures 
To ensure the viability and growth of single cells, a 1:1 mix of conditioned media and 
fresh media was used. Conditioned media is basically media in which cells have been 
cultivated for a period of time. This medium is used as a supplement as they contain 
growth factors and cytokines otherwise not present in fresh media.  
Chapter 3  Materials and methods 
  27 
Conditioned media was prepared by collecting media from confluent 
CHO/dhfr-GFP cell cultures in T-flasks and spinning it down at 2500rpm for 10 
minutes to remove floating cells and cell debris. The supernatant was collected and 
spun down again to ensure complete removal of cell debris before mixing it with fresh 
culture media (DMEM, 10% FBS) in a 1:1 ratio. 150µl of this 1:1 media mix was 
aliquoted into each well of the 96-well plate before single cell sorting was carried out. 
After sorting, clones were maintained in a humidified 5% CO2 environment at 
37oC. Media was topped up periodically using the 1:1 media mix until cells were 
confluent (about 2 to 3 weeks), after which cells were transferred to 24-well plates 
containing fresh culture media. Once the cells reached confluence, they were 
transferred to 6-well plates followed by 25 cm2 T-flasks (Figure 3.8). 
Figure 3.8: Obtaining clones of varying fluorescence through FACS sorting and single 
cell cultures. 
 
Clones were maintained in 25 cm2 T-flasks for 4 passages before 
cryopreservation. Fresh media (DMEM, 10% FBS) supplemented with 10% DMSO 
(Sigma) and 10% FBS was used to preserve each clone in –152oC, at a concentration 
of 5 x 106 cells/ml.  
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All isolated clones were maintained in 25 cm2 T-flasks for 8 weeks and their 
GFP production was monitored by FACS. Two clones exhibiting stable GFP 
production were eventually selected for further analysis. The clone with high 
fluorescence is denoted as high producer (HP) while the clone with low fluorescence 
is denoted as low producer (LP). 
3.2.5 Suspension cell cultures 
HP and LP cells were adapted for growth in suspension culture in HyQ PF-CHO MPS 
media (Hyclone) supplemented with 4mM Glutamine (Sigma) and 0.01% Pluronic 
F68 (Gibco). Media replacement was first carried out, followed by gradual removal of 
FBS (Figure 3.9). Cells were adapted when they show >95% viability over a 3 or 4 
day culture with no tendency to form cell clumps. Adapted cells were maintained in 
cultures of 20ml in 125ml shake flasks (Corning Inc.) for 4 passages before 
cryopreservation. Fresh media (HyQ PF-CHO MPS media, 4mM Glutamine, 0.01% 
Pluronic F68) supplemented with 10% DMSO (Sigma) was used to preserve each 
clone in –152oC, at a concentration of 1 x 107 cells/ml.  
Figure 3.9: Adapting HP and LP from attached cultures to suspension cultures. 
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3.3 GFP ELISA 
The amount of dhfr-GFP each clone produced was quantified using the ELISA 
(Enzyme-Linked Immunosorbent Assay) method. First, total protein was extracted 
from attached cells grown in 6-well plates using M-PER mammalian protein 
extraction reagent (PIERCE) as per manufacturer’s recommendations. This was 
followed by the determination of total protein concentration (µg/µl) using the BCA 
(Bicinchoninic Acid) protein assay kit (Pierce) with BSA as standards. 
5µg of total protein was loaded into each well of Reacti-bind anti-GFP coated 
plates (Pierce) with purified GFP (Clonetech) as standards. During incubation, dhfr-
GFP from the total protein will bind to the anti-GFP antibody coated on the well. 
Unbound proteins were removed by washing with PBST (Phosphate Buffered Saline, 
0.1% Tween20). This was followed by another round of incubation with AP (alkaline 
phosphotase) conjugated anti-GFP antibody that will bind to exposed regions of dhfr-
GFP in the well. After washing away the unbound AP-conjugated antibody, the bound 
conjugate was detected by reaction with 1-step PNPP (p-Nitrophenyl Phosphate, 
Disodium Salt) substrate (Pierce). The reaction was stopped by adding NaOH to give 
a colorimetric endpoint that was read spectrophotometrically (A405) by a microwell 
plate reader (Spectra Rainbow, Tecan). 
3.4 Sample collections for microarray and iTRAQ 
3.4.1 Cell counts and viability 
The number of cells was determined using a hemocytometer.  Cell density and 
viability were determined by the trypan blue (Sigma) exclusion method (Freshney, 
1994) after the sample was suitably diluted with PBS. 
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3.4.2 Growth kinetics 
Cells were grown as batch cultures of 100ml with an initial inoculation of 3 x 105 
cells/ml in 500ml shake flasks (Corning Inc.). 1ml of culture was taken for cell count 
over a period of 6 days where the growth curve is obtained. It was found that the 
exponential growth phase is on day 3, and stationary phase on day 6 (Figure 3.10). 
Figure 3.10: Growth kinetics curve of HP and LP. Arrows indicate sampling points 
for microarray and iTRAQ experiments. 
 
3.4.3 Cell samples 
Cell samples were obtained from suspension cultures of HP and LP cells in the mid-
exponential growth phase (day 3) and the stationary phase (day 6). Three biological 
replicates (MEP1, MEP2 and MEP3) of 1 x 108 cells each was collected for 
microarray analysis in the mid-exponential phase, while 3 x 107 cells were collected 
for iTRAQ in the mid-exponential (MEP1) and stationary phase (SP1). Samples for 
microarray and iTRAQ in the mid-exponential phase were aliquoted from the same 
batch culture (Figure 3.11). Batch cultures of cells were grown in 500mL shake flasks 
(Corning Inc.) with working volumes of 100ml in a 37oC, 5% CO2 incubator. Cells 
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were collected by centrifugation (Beckman) at 950rpm for 5 minutes and removing 
the supernatant. Cell pellets were stored at –80oC before analysis. 
Figure 3.11: HP and LP cell samples collected for microarray and iTRAQ analysis. 
 
3.5 Microarray 
3.5.1 CHO cDNA microarray 
CHO cDNA microarrays were made from cDNA clones obtained by sequencing of 
CHO cDNA library (Wlaschin et al, 2005) and were produced by the Microarray 
Department in the Bioprocessing Technology Institute. The microarray has a total of 
14,064 CHO cDNA elements of which 7,559 genes are unique.  The genes cover the 
functional groups shown in Table 3.1. 
MEP1 MEP2 MEP3 SP1 
1 x 108 
cells 
3 x 107 
cells 
1 x 108 
cells 
1 x 108 
cells 















MEP:  Cells in mid-exponential phase 
SP: Cells in stationary phase 
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 Gene Functional Groups Number of genes 
 
 
 B-cell development  52  
 XBP targets 23  
 AA transporters 12  
 Apoptosis 60  
 Cell-organism defense/homeostasis/carrier proteins 80  
 Glycosylation 10  
 Lipid metabolism 92  
 Glycolysis 132  
 TCA cycle 35  
 Monocarboxylate transporter 12  
 Pentose phosphate pathway 12  
    
Table 3.2: List of functional groups covered in 15k CHO cDNA microarray chip.  
 
In addition to the CHO cDNA spotted on the slide, controls and ‘landing 
lights’ were included for the identification of subarrays during post-scanning spot-
alignment. CHO cDNA, controls and landing lights were spotted in duplicates, giving 
a total of 28,416 elements printed on the slide. 
 
3.5.2 Experimental design 
Transciption profiling was performed for samples in the exponential growth phase 
where gene expression of HP was compared against LP. Three technical replicates 
were carried out for each biological replicate to give a total of 9 experiments and 3 
data sets. One microarray slide was used for each experiment and slides from the 
same batch were used. Values for each data set were obtained after normalizing and 
averaging values from the 3 technical replicates (Figure 3.12). The technical 
replicates included a dye-swap in which the dye labeling was reversed to account for 
any sample dye-bias.  
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Figure 3.12: Experimental design for transcription profiling. 
 
3.5.3 Total RNA extraction 
Total RNA was extracted from cell samples (1 x 108 cells) using Trizol® reagent 
according to the manufacturer’s protocol (Invitrogen). Briefly, cells were lysed in 
Trizol® reagent and RNA was obtained via phase extraction using chloroform (EM 
Science). RNA was subsequently purified by isopropanol precipitation and dissolved 
in an appropriate amount of DEPC (diethyl pyrocarbonate) treated water to yield 2-
3µg RNA/µl. RNA samples were examined on a 1% denaturing RNA gel to ensure no 
RNA degradation after extraction. Total RNA concentration and purity was 
determined using a UV spectrophotometer (GeneQuant Pro, Amersham Biosciences). 
3.5.4 Preparation of target DNA 
The target DNA is defined as the fluorescent-labeled DNA that is applied to the 
microarray and undergoes hybridization with the complementary cDNA (probe) 
attached to the surface of the slide. The target DNA was produced through reverse 
transcription of poly-A mRNA into cDNA where Cyanine dye-conjugated nucleotides 
Biological Replicate 1 
(MEP1) 
Biological Replicate 2 
(MEP2) 
Biological Replicate 3 
(MEP3) 
HP (Cy5) LP(Cy3) 
HP (Cy5) LP(Cy3) 
HP (Cy3) LP(Cy5) 
HP (Cy5) LP(Cy3) 
HP (Cy5) LP(Cy3) 
HP (Cy3) LP(Cy5) 
HP (Cy5) LP(Cy3) 
HP (Cy5) LP(Cy3) 
HP (Cy3) LP(Cy5) 
Data set 1 
Data set 2 
Data set 3 
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were incorporated.  Following convention, control samples (LP) and experimental 
samples (HP) were labeled with Cyanine 3 (Cy3) and Cyanine 5 (Cy5) dyes 
respectively. Cy3 and Cy5 have distinctly different excitation and emission 
wavelengths (excitation/emission Cy3: 550/570 nm and Cy5 649/670). Their 
fluorescent signals are produced when light of the appropriate excitation wavelength 
illuminates the microarray slide. The signal can then be detected by measuring the 
emitted fluorescence intensity. As Cy dyes are light sensitive, all subsequent steps up 
till the scanning of slides were performed away from light. 
cDNA for each sample was synthesized and directly labeled with either Cy3 or 
Cy5 dyes (Perkin Elmer) from 25µg of total RNA using RevertAidTM H- Minus M- 
MuLV Reverse Transcriptase (Fermentas), according to the manufacturer’s 
recommendations. The cDNA synthesis reaction was hydrolyzed by adding EDTA; 
followed by NaOH to final concentrations of 0.1M and 0.2M respectively, and an 
additional incubation at 65°C for 15 minutes.  The hydrolysis reaction was cooled to 
room temperature and neutralized by adding 5M Acetic acid to a final concentration 
of 0.4M. The dye-coupled DNA were combined and purified using MinElute™ PCR 
Purification kit according to the manufacturer’s protocol (Qiagen) and eluted in 11µl 
of nuclease free water.  
3.5.5 Pre-hybridization 
Pre-hybridization of the microarrays was first carried out to reduce unspecific binding 
of target to the microarray, thus lowering background noise.  Pre-hybridization buffer 
X (5x SSC, 50% deionized formamide, 0.1% SDS, 1% BSA) was applied to the slide 
and was allowed to spread slowly under a liferslip (Erie Scientific Company) as it was 
gently lowered. The slide was then encased in a humidified, watertight hybridization 
chamber, and was incubated in a 42oC water-bath for 1 hour.  The hybridization 
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chamber was kept moist by the addition of 40µL 20x SSC on the bottom surface of 
the chamber. After incubation, the slides were washed by immersion in ddH2O (Milli-
Q, Millipore) and spun dry before proceeding to hybridization.  
3.5.6 Hybridization 
Hybridization is the process of incubating the cyanine-labeled target DNA with the 
probe DNA on the microarray. The target DNA will hybridize to the complementary 
probe DNA on the slide, and the amount of immobilized fluorescence can then be 
determined by scanning. 
Blockers (1µg poly(dA), 10µg yeast tRNA, 10µg mouse COT1 DNA) and 
landing lights (Cy3-K01391 and Cy5-X17013 at 1µl each) were first added to the 
purified target DNA, followed by 25µl of pre-warmed (42°C) 2X hybridization buffer 
(50% formamide, 5x SSC, 0.1% SDS, 1% BSA). Blockers were used to prevent non-
specific binding during hybridization, as detailed in Table 3.3. 
    
 Blocker Function 
 
 
 Poly(dA) Blocks hybridization to eukaryotic polyA tails  
 Yeast tRNA General bulk blocker against non-specific hybridization  
 Mouse COT1 DNA Blocks hybridization to mouse repetitive sequences  
    
Table 3.3: List of blockers used in microarray hybridization 
 
This target DNA/blocker mixture was incubated at 95°C for 5 minutes to 
denature the target DNA and prevent unwanted self-complimentary binding. The 
mixture was snap-cooled on ice before application to the arrays under a lifterslip.  The 
arrays were then encased in a humidified watertight hybridization chamber (as 
described in section 3.5.5) and hybridization of the labeled targets to the microarrays 
was conducted for a minimum of 16 hours in a 42°C water bath in the dark.  
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3.5.7 Washing 
After hybridization, liferslips were removed in washing buffer I (1x SSC, 0.2% SDS) 
in the dark. The microarrays were washed sequentially for 5 minutes, twice, in buffer 
II (2x SSC), buffer III (0.1x SSC, 0.1% SDS), and buffer IV (0.1x SSC).  The 
microrrays were dried by centrifugation at 1000rpm for 2 minutes and stored in the 
dark until scanning. 
3.5.8 Scanning and image analysis 
Microarrays were scanned using an Axon GenepixTM 4000B scanner (Molecular 
Devices Corp.). The scanner uses a dual laser scanning system were it acquires data at 
two wavelengths simultaneously. Genepix lasers excite at 532 nm (green) and 635 nm 
(red) and the emission filters used are 575DF35 (green; ~557-592 nm) and 670DF40 
(red; ~650-690 nm). Exposure settings were adjusted during scanning to minimize 
background and saturated spots. Scanned image can be saved in *.tiff format and 
exported (Figure 3.13). 
 
Figure 3.13: Scanned image of a section in hybridized microarray. Comparative 
analysis of HP (Cy5-labeled) and LP (Cy3-labeled).  
 
Image analysis was performed using GenePixTM Pro 4.1 analysis software. A 
reference grid was first superimposed on the scanned image to identify each spot 
(Figure 3.14). The grid comes in the form of a *.gal (Gene Array List) format file and 
it contains all the necessary information needed to identify each spot (coordinates, 
name, identifiers) on the array. After the reference grid is properly positioned, spots 
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that were visibly damaged by artifacts (scratches, etc) or spot areas with any 
imperfections (unprinted, etc) were flagged off. At the end of spot validation, the 
intensity data of each spot is extracted by the conversion of pixels into digital 
intensity, generating a *.gpr (Genepix results) file. 
Figure 3.14: (a) Reference grid before spot alignment (b) Reference grid after 
alignment. 
 
3.5.9 Data normalization and analysis 
Data normalization is required due to various sources of systematic variances present 
in microarray experiments. These include (i) differences in labeling efficiency, 
intensity and hybridization properties between Cy3 and Cy5, (ii) dye biases dependant 
on overall spot intensity and spatial location on the array, and (iii) difference in 
experimental conditions across slides. Both within-slide normalization and scale 
normalization across slides was conducted on the intensity data (*.gpr file) obtained 
based on methods adapted from Yang et al (2002). Normalized gene expression 
values were expressed as the log2 intensity ratio of high producer with respect to low 
producer. A t-test was performed on the log-transformed ratios to check the 
reproducibility of data within each data set. Genes with greater than 1.5-fold change 
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(i.e. log2(HP/LP)>0.585 or log2(HP/LP)<-0.585) and p<0.05 in a data set were 
considered to be significantly regulated.  
 
3.6 Proteomic analysis 
3.6.1 Cell lysis and protein concentration assay 
Samples (3 x 107 cells) were lysed in 500µl of 0.5M triethyammonium bicarbonate, 
(Applied Biosystems), 1mM Phenylmethylsulphonylfluoride (PMSF; Sigma), 0.04% 
SDS (Sigma), 0.1% Triton-X 100 (Sigma), 50µg/ml DNase (Roche Diagnostics) and 
RNase (Boehringer Mannheim). Samples were vortexed and syringed for 15 minutes 
to ensure complete lysis and centrifuged at 20,000g for 20 minutes to clarify the 
lysate. Protein concentration was estimated using the Coomassie Plus Bradford assay 
reagent (Pierce) with BSA as a protein standard. 
3.6.2 Protein labeling 
Aliquots of cell lysates (200µg each) were labelled with iTRAQTM reagents (Applied 
Biosystems) as per manufacturer’s protocol. Briefly, proteins were reduced and 
modified with methyl methane thiolsulphonate (MMTS) before digestion with 1:50 
trypsin (Promega) to substrate ratio at 37oC for 16 hours. Each peptide pool was then 
labeled separately with an appropriate iTRAQTM mass tag reagent (114, 115, 116 or 
117) before they were pooled together (Table 3.4). 
    
 Samples iTRAQTM mass tag reagent 
 
 
 LP MEP1 114  
 LP SP1 115  
 HP MEP1 116  
 HP SP1 117  
    
Table 3.4: Cell samples and their respective iTRAQTM mass tag reagent. 
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3.6.3 Peptide separation 
The pool of labeled peptides was diluted up to a 3ml volume with the column 
equilibration solvent (10mM KH2PO4, 20% acetonitrile, pH 3). Injection of the 
diluted sample was performed in multiple aliquots onto a strong cation exchange 
column (PolyLC 2mm x 150mm, PolyMicro Technologies). Before sample injection, 
the baseline was monitored using a UV signal at 214nm until it was stabilized, usually 
after 30 minutes of washing. Peptides were separated by developing a gradient of 
potassium chloride (10mM KH2PO4, 20% acetonitrile, 500mM KCl, pH 3) over 60 
minutes at a flow rate of 150µl per minute, and collecting fractions every two minutes. 
After separation, each fraction was de-salted using a C18 ZipTipTM (Millipore). Each 
peptide fraction was finally eluted in 70% acetonitrile, 0.1% formic acid and 
concentrated to remove acetonitrile in a SpeedVac (Savant). Each of the fractions was 
then reconstituted in 20µl of 1% formic acid, 2% methanol in ddH2O (Milli-Q, 
Millipore) and stored at -80oC until further analysis. 
3.6.4 Mass spectrometry of LC separated peptides 
Half of each concentrated fraction was used to inject onto an on-line nano LC-MS/MS 
system using a FAMOS (LC-Packings/Dionex) auto-injector. 7µl of the sample was 
taken up from each vial and loaded onto a reversed-phase, C-18 peptide trapping 
cartridge (300um x 5mm, LC-Packings/Dionex) with a flow of 0.1% formic acid at 
25µl per minute. After peptides were bound to the cartridge, washing continued for 
another 5 minutes to remove any salts remaining in the sample. After 5 minutes, the 
flow was switched via a ten-port valve (Switchos, LC-Packings/Dionex) to allow a 
nano-flow rate of 100nl per minute of the same solvent to back-flow through the 
cartridge using an Ultimate (LC-Packings/Dionex) nano-flow pumping system. After 
a further five minutes, a gradient from 0.1% formic acid to 90% acetonitrile in 0.1% 
Chapter 3  Materials and methods 
  40 
formic acid over 40 minutes at 100nl per minute was applied to the column. Peptides 
eluting from the cartridge were passed into a separating column comprising of a 75µm 
x 10cm packed volume of 5µm C-18 reversed phase packing (Column Engineering). 
The separating column was mounted on a PicoView ESI source (NewObjective) 
utilizing a T-junction providing a voltage of 2200V to the liquid flow. Peptides 
eluting from the column were sprayed directly into the orifice of a QSTAR-Pulsar I or 
QSTAR-XL (Applied Biosystems) hybrid quadrupole-time of flight tandem mass 
spectrometer. The instrument was run in IDA (information dependent acquisition) 
mode selecting all 2+ to 4+ charged ions with signal intensity greater than 8 counts 
per second over the mass range of 300 – 2000amu. Collision induced dissociation 
(CID) nitrogen gas was used at a setting of 4 and the collision energy set to automatic, 
allowing increased energy with increasing ion mass. Each fraction that was run 
generated a *.wiff file which was searched against the mouse sub-set of the IPI 
protein database using the MASCOT search engine. From the search results a mass 
exclusion list was generated for each fraction based on the peptide masses of all 
matching peptides or up to a maximum of 2000 masses. These masses were then used 
to exclude those matches already obtained and the remaining half of each fraction was 
re-run generating a second set of *.wiff files. 
3.6.5 Protein identification and quantification 
The complete set of data files (*.wiff) was analysed together using the ProQuantTM 
and ProGroupTM suite of software (Applied Biosystems) and searched using the 
mouse, rat and human sub-sets of the IPI protein database (version 3.13). 
Identification and quantification of proteins were achieved by ProQuant analysis, 
followed by ProGroup functionality analysis which suppressed redundant and similar 
proteins into “protein groups”, and determined protein identity confidence for all 
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proteins. To minimize errors in identification, all proteins have to satisfy two criteria: 
(i) possessed minimal 95% ID confidence as determined by ProGroup, and (ii) 
possessed at least two distinct peptides whose sequence were identified with minimal 
95% confidence by ProQuant. In subsequent quantification analysis, data was 
manually edited to ensure that equivalent proteins were only represented once by the 
highest scoring, and those with quantification having error factors (EF) greater than 
two were excluded. EF values accounted for the 95% confidence interval of the ratio, 
with the upper limit defined as “ratio*EF” and the lower limit as “ratio/EF”. Upper 
and lower limit ratios were denoted as (HP116:LP114 max) and (HP116:LP114 min) 
for the mid-exponential phase data set and (HP117:LP115 max) and (HP117:LP115 
min) for the stationary phase data set. To correct for unintentional bias in combining 
equal amounts of labeled components, all observed ratios within each set of ratios 
were divided by its median ratio on the underlying assumption that the majority of 
proteins remained unchanged in expression with a ratio of 1. Differentially regulated 
protein was defined as one having greater than 1.2 times change in expression level in 
the high producer versus the low producer. Care was taken to ensure 95% confidence 
of accuracy in identifying regulated proteins (i.e. “ratio*EF” < 0.83 or “ratio/EF” > 
1.2). 
3.7 Quantitative real-time PCR 
Five genes were randomly chosen to validate microarray results using quantitative 
real time PCR (QRT-PCR). QRT-PCR was performed on an ABI Prism 7000 
Sequence Detector System (Applied Biosystems) on HP and LP samples.  Total RNA 
was first extracted from cells as described for microarray analysis (Section 3.5.3).  An 
additional step of genomic DNA removal using DNase I was performed prior to 
cDNA synthesis. cDNA was generated using IMPROM II reverse transcription 
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system (Promega) according to the manufacturer’s protocol. Each 25µl QRT-PCR 
reaction comprises of cDNA (1 ng/µl), ITAQ SYBR I 2x Master Mix (Biorad) and 
gene-specific primers at a concentration of 50nM. The primers used for each gene are 
listed in Table 3.5.  All reactions were performed in triplicate.  Cycling parameters 
were 95oC for 10 min followed by 40 cycles of 95oC for 15s and 60oC for 1min.  
Relative quantification was performed using the comparative Ct (2-∆∆CT) method 
(Livak and Schmittgen, 2001). 
 
   
 
 Gene Description Primer Sequences 
 
 
 Hyou1  
 




 Mtif  
 
Mitochondrial translational 





 Ppib Peptidyl-prolyl cis-trans 














 eEF1a1 Eukaryotic translation 






 Farslb Phenylalanine-tRNA 




     
Table 3.5: List of genes validated by QRT-PCR and their respective primers.  
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4 RESULTS 
4.1 Construction of screening vector 
In this study, the screening vector was developed to identify chromosomal locations 
with stable and high transcription activity. The vector contains a reporter marker, GFP, 
tagged to the selection marker, dhfr, creating a fusion protein that was expressed in 
CHO/dhfr- cells.  
Cells started to fluoresce 24 hours after transfection and exhibited various 
levels of fluorescence after 1 week in selective media (Figure 4.1 and Figure 4.2), 
thus demonstrating the functionality of the fusion protein. The wide range in GFP 
expression levels is shown by the difference in the FACS profiles of CHO/dhfr- and 
CHO-dhfr-GFP after 2 weeks in selective media (Figure 4.3). 
Figure 4.1: CHO/dhfr- cells 24 hours after transfection with screening vector pSV2-
dhfr-GFP. (a) Cells under normal illumination. (b) Fluorescent cells. 
Figure 4.2: CHO-dhfr-GFP cells after 1 week in selective media. (a) Cells under 
normal illumination. (b) Fluorescent cells. 
(a) (b) 
(a) (b) 
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Figure 4.3: FACS profile of CHO/dhfr- and CHO-dhfr-GFP after 2 weeks in selective 
media. A shift of profile towards the right indicates higher fluorescence intensity. 
 
4.2 Selection of high and low producers 
GFP is used as a fluorescent protein marker to screen for high producing clones by 
fluorescence-activated cell sorter (FACS). Clones exhibiting high fluorescence 
intensity usually correlates to high recombinant protein production (Meng et al, 2000) 
and this property was used to select populations of CHO cells expressing different 
levels of GFP. 
4.2.1 FACS sorted clones 
After 2 weeks of growth in selective media, CHO-dhfr-GFP cells were sorted as 
single cells into 96-well plates. 2 plates each of high and low fluorescing cells were 
sorted as mentioned previously (section 3.2.3). Out of 384 clones sorted, only 38 
remained viable to be expanded into 25cm2 T-flasks. Initial visual observations and 
CHO/dhfr- 
CHO-dhfr-GFP 
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subsequent FACS analysis showed a good distribution of clones expressing various 
levels of GFP (Figure 4.4 and Figure 4.5). 
Figure 4.4: Various clones with observable fluorescence. 
 
Figure 4.5: FACS profile of various clones. Clones 1 to 3 were sorted as low 














Clone 1 Clone 3 Clone 6 Clone 4 
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4.2.2 Stability of GFP production 
Viable clones were maintained in 25cm2 T-flasks for 2 months and FACS was used to 
monitor their GFP production periodically. Out of 38 clones, only 12 clones showed 
extremely stable GFP production profiles (Figure 4.6). The remaining clones either 
showed a constant decrease in GFP expression (Figure 4.7), or an initial decrease 
followed by stable GFP expression (Figure 4.8). 
Figure 4.6: Clones with stable GFP production. 
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Figure 4.8: Clones showing an initial decrease, followed by constant GFP production.  
 
The 12 stable clones were maintained for another month and their productivity 
was checked by FACS. From these 12 clones, a high producer (HP) and low producer 
(LP) was selected (Figure 4.9) and adapted for suspension culture. 









Week1   Week4   Week12 
Week2   Week6 
Week3   Week8 
Low Producer High Producer 
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4.2.3 GFP quantification 
GFP ELISA was carried out to quantify the amount of GFP produced from HP and LP 
(Table 4.1). On average, HP cells make 6x more GFP than LP. 
 Amount of GFP per total protein (ng/µg) 
 
Samples Biological Replicate 1 Biological Replicate 2 
 
CHO/dhfr- 0.037  0.012 
CHO-DHFR-GFP 0.043  0.064 
LP 0.107  0.098 
HP 0.506  0.527 
LP (normalized) 0.070  0.086 
HP (normalized) 0.469 0.515 
HP:LP ratio 6.0 6.7 
Table 4.1: GFP ELISA results. 
 
4.2.4 Growth differences between HP and LP 
After HP and LP clones were adapted to suspension cultures, their growth curve was 
monitored over a span of 6 days. Although growth profiles were similar, it was 
apparent that HP had a lower cell density as compared to LP (Figure 4.10). 
Figure 4.10: Growth kinetics of HP and LP during sampling. 
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4.3 Transcriptomic analysis 
4.3.1 Overview of gene regulation 
Comparitive analysis of transcript levels between HP and LP in the mid-exponential 
phase was performed using a 15k CHO cDNA microarray chip, of which 7559 genes 
are unique. To obtain an overview of the transcriptomic profile of HP, differentially 
regulated genes were first classified under categories based on their functions (Table 
4.2). Table 4.3 and Figure 4.11 summarize the differential regulated genes between 









The chemical reactions and pathways involving a specific 








 Cell Cycle The progression of biochemical and morphological phases 
and events that occur in a cell during successive cell 





The cascade of processes by which a signal interacts with a 
receptor, causing a change in the level or activity of a second 
messenger or other downstream target, and ultimately 
effecting a change in the functioning of the cell. 
 
 
 Cytoskeleton The assembly and arrangement of cytoskeletal structures. 
 
 
 Transport The directed movement of substances (such as 
macromolecules, small molecules, ions) into, out of, within 





















 Unknown Genes with unknown function or novel sequences.  
    
Table 4.2: Description of various categories used for the classification of genes. 
Definitions were obtained from the gene ontology database. 
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Function Up-regulated Down-regulated Total 
Protein Metabolism 12 1 13 
Transcription 6 1 7 
Cell Cycle 2 5 7 
Signal Transduction 2 3 5 
Cytoskeleton 3 2 5 
Transport 2 2 4 
DNA Metabolism 1 1 2 
Lipid Metabolism 2 0 2 
Carbohydrate Metabolism 0 1 1 
Unknown 15 17 32 
Total 45 33 78 
Table 4.3: Overview of differentially regulated genes with >1.5 fold change and 
p<0.05. 
Figure 4.11: Genomic profile of differentially regulated genes for high producing cell 
line in mid-exponential growth phase. 
 
Microarray analysis reveals that high producer CHO cells had 45 genes up 
regulated and 33 down regulated. Using a combined selection criteria of p value less 
than or equal to 0.05 (95% confidence) and a differential expression of 1.5 fold or 
more, only 78 genes from the 7559 unique sequences were classified as statistically 
significant. As shown in Table 4.3 and Figure 4.11, the majority of genes were in 3 

















Oxidative Stress Response 
Unknown 
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cell cycle (9%). Protein metabolism and transcription contributed to the bulk of 
known up-regulated genes (18 out of 30) and cell cycle has the largest number of 
genes down regulated. A major portion (41%) of the filtered genes had unknown 
functions and these could be a source for discovery of new and novel genes.  
4.3.2 List of differentially regulated genes 
Stringent conditions for filtering (fold-change levels reproducible over 3 data sets, 
with ≥1.5 fold change and p ≤0.05) were used initially but only yielded a list of 8 
genes (Table 4.4). To obtain a broader view of the transcription profile, the final list 
of genes was decided based on the values of one dataset that shows ≥1.5 fold change 
and p ≤0.05 (Table 4.5). In general, the observed fold-changes were relatively small, 
with the log2 ratios not exceeding 3 (8-fold change) in all cases. Most of the genes 
have a log2 ratio between 0.585 (1.5-fold) and 1.3 (2.5-fold). Several genes (Cox7a2, 
Eef1a1, Elovl5, Mapk6, Nedd4, Rps2, Rps27, Rpl37a, Tmsb4x, Gja1 and S100a6) 
were identified more than once, as there were multiple spots printed on the microarray. 
Genes with less than 3 data sets was due to the flagging-off of bad spots as mentioned 
previously (section 3.5.8).  
The differentially expressed genes identified and their functions are as listed in 
Table 4.6. Up regulated genes were mainly involved in protein synthesis, 
ubiquitylation, transcription regulation and mRNA splicing. Mitochondrial genes and 
genes in lipid metabolism were also up regulated while cell growth and maintenance 
genes were down regulated. Interestingly, there was no change detected in Unfolded 
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Arih1 1.03 0.00 0.89 0.00 0.94 0.03 
Cox7a2 0.93 0.00 0.81 0.00 0.86 0.03 
Eef1a1 1.16 0.00 0.93 0.01 0.86 0.02 
Eef1a1 1.06 0.00 0.93 0.00 0.86 0.02 
Eef1a1 0.86 0.00 0.70 0.00 0.59 0.02 
Eef1a1 0.93 0.00 0.81 0.00 0.61 0.04 
Nedd4 1.15 0.00 0.99 0.00 0.84 0.03 
Yt521 0.65 0.00 0.65 0.00 0.71 0.03 
Peli1 0.81 0.00 0.59 0.00 0.67 0.00 
Novel 
Sequence 
0.90 0.00 0.86 0.00 0.77 0.00 
Down regulated genes 
S100a6 -1.34 0.01 -1.29 0.01 -0.81 0.03 
Table 4.4: List of differentially regulated genes based on stringent conditions. Fold-
change levels reproducible over 3 data sets (≥1.5 fold change and p ≤0.05). 
 
 Data set 1 Data set 2 Data set 3 












Up regulated >2 fold 
16S rRNA N N N N 1.40 0.01 
Arih1 1.03 0.00 0.89 0.00 0.94 0.03 
CAP1 N N 1.41 0.00 N N 
Ccdc28a 0.40 0.00 -0.04 0.36 1.49 0.00 
Cox7a2 1.13 0.00 1.13 0.01 1.03 0.06 
Eef1a1 1.16 0.00 0.93 0.01 0.86 0.02 
Eef1a1 1.06 0.00 0.93 0.00 0.86 0.02 
Eef1a1 1.06 0.00 0.72 0.03 0.42 0.06 
Fth1 0.08 0.31 0.00 0.37 1.08 0.01 
Lsm8 0.12 0.00 1.03 0.00 0.76 0.00 
Macf1 0.07 0.31 -0.13 0.29 1.02 0.01 
Nedd4 1.15 0.00 0.99 0.00 0.84 0.03 
Psma4 0.71 0.00 N N 2.65 0.00 
Novel N N N N 2.93 0.00 
Novel 0.11 0.27 0.00 0.37 1.14 0.01 
Down regulated >2 fold  
Cstf2t 0.18 0.12 -1.09 0.00 -0.11 0.00 
Ercc5 -0.10 0.14 N N -1.06 0.00 
Hspa5 -1.06 0.00 -0.93 0.01 -0.10 0.23 
Rtn4 0.04 0.36 N N -1.02 0.00 
S100a6 -1.34 0.01 -1.29 0.01 -0.81 0.03 
Novel -1.30 0.00 -1.08 0.03 -0.84 0.05 
Novel -1.01 0.00 -1.18 0.01 -0.01 0.37 
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 Data set 1 Data set 2 Data set 3 












Down regulated >2 fold 
Novel 0.31 0.00 -0.47 0.00 -1.07 0.00 
Up regulated >1.5 fold 
1810007M14Rik 0.63 0.00 0.52 0.01 0.40 0.01 
Anxa2 0.59 0.00 0.39 0.00 0.38 0.03 
Ccng2 0.79 0.00 0.62 0.02 0.28 0.10 
Cox7a2 0.93 0.00 0.81 0.00 0.86 0.03 
Dci 0.67 0.00 0.67 0.00 0.38 0.18 
Eef1a1 0.64 0.00 0.77 0.00 0.54 0.00 
Eef1a1 0.86 0.00 0.70 0.00 0.59 0.02 
Eef1a1 0.93 0.00 0.81 0.00 0.61 0.04 
Elovl5 0.63 0.00 0.64 0.02 0.38 0.13 
Elovl5 0.90 0.00 0.70 0.03 0.47 0.11 
Gsg2 0.73 0.00 0.57 0.03 0.49 0.05 
Hmgn3 0.90 0.00 0.71 0.01 0.52 0.01 
Larp5 0.48 0.00 N N 0.85 0.00 
Mapk6 0.51 0.00 0.64 0.00 0.15 0.01 
Mapk6 0.74 0.00 0.46 0.02 0.31 0.18 
MrpL35 0.53 0.00 0.59 0.00 0.53 0.02 
Nedd4 0.89 0.00 0.80 0.00 0.47 0.10 
Nedd4 0.97 0.00 0.57 0.03 0.32 0.11 
Nedd4 0.65 0.00 0.53 0.03 0.20 0.23 
Peli1 0.81 0.00 0.59 0.00 0.67 0.00 
Phca 0.74 0.00 0.71 0.00 0.59 0.05 
Psmc5 0.75 0.00 0.56 0.00 0.53 0.05 
Recql 0.66 0.00 0.63 0.00 0.34 0.24 
RGD1311532_predicted 0.32 0.00 N N 0.71 0.01 
Rps2 0.89 0.01 0.69 0.00 -0.03 0.37 
Rps2 0.95 0.00 0.85 0.01 0.17 0.17 
Rps2 0.86 0.01 0.76 0.03 0.31 0.03 
Rps27 0.69 0.00 0.77 0.03 0.47 0.01 
Rps27 0.73 0.00 0.76 0.02 0.41 0.03 
Sfrs5 0.62 0.00 0.66 0.00 0.42 0.17 
Ube2a 0.56 0.01 0.39 0.03 0.67 0.05 
Ubxd2 0.94 0.00 0.64 0.00 0.82 0.05 
Usp10 0.82 0.00 0.54 0.01 0.49 0.06 
Yt521 0.65 0.00 0.65 0.00 0.71 0.03 
Novel 0.45 0.00 0.33 0.23 0.65 0.05 
Novel 0.61 0.00 0.56 0.00 0.40 0.16 
Novel 0.87 0.00 0.44 0.01 0.63 0.16 
Novel 0.96 0.00 N N 0.49 0.00 
Novel 0.60 0.00 0.38 0.01 0.43 0.01 
Novel 0.90 0.00 0.86 0.00 0.77 0.00 
Novel 0.93 0.00 0.56 0.07 0.40 0.00 
Novel 0.63 0.00 0.39 0.02 0.43 0.07 
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 Data set 1 Data set 2 Data set 3 












Up regulated >1.5 fold 
Novel 0.72 0.00 0.52 0.00 0.42 0.01 
Down regulated >1.5 fold  
Bcl10 N N N N -0.84 0.00 
1600029D21Rik -0.68 0.00 -0.75 0.03 -0.20 0.28 
Atp5g3 -0.63 0.00 N N N N 
BLOC1S1 N N N N -0.59 0.00 
C330006A16Rik N N N N -0.63 0.00 
Gja1 -0.70 0.00 -0.60 0.04 -0.54 0.07 
Gja1 -0.74 0.00 -0.74 0.08 -0.54 0.20 
Igfbp4 -0.72 0.00 -0.58 0.06 -0.51 0.00 
Mpp1 N N -0.87 0.01 N N 
Ndufa8 -0.58 0.00 -0.60 0.00 -0.15 0.31 
Pgm2 N N N N -0.67 0.00 
Ptma -0.29 0.01 -0.40 0.09 -0.81 0.02 
Rpl37a -0.68 0.00 -0.56 0.03 -0.42 0.16 
Rpl37a -0.64 0.00 -0.44 0.03 -0.57 0.00 
Rpl37a  -0.75 0.00 -0.51 0.02 -0.56 0.05 
S100a6 -0.95 0.00 -0.53 0.07 -0.45 0.10 
Tmsb10 -0.44 0.00 -0.77 0.03 -0.58 0.17 
Tmsb4x -0.64 0.00 -0.50 0.01 -0.30 0.02 
Tmsb4x -0.79 0.00 -0.60 0.00 -0.36 0.02 
Tmsb4x -0.89 0.00 N N -0.11 0.25 
Novel -0.61 0.00 -0.53 0.07 -0.10 0.15 
Novel -0.73 0.00 -0.70 0.02 -0.26 0.03 
Novel -0.67 0.00 -0.62 0.00 -0.11 0.02 
Novel -0.61 0.00 -0.54 0.02 -0.07 0.32 
Novel -0.78 0.01 -0.74 0.00 -0.36 0.14 
Novel N N -0.86 0.00 N N 
Novel N N N N -0.66 0.00 
Novel -0.71 0.00 -0.57 0.01 -0.25 0.19 
Novel -0.66 0.01 -0.90 0.00 -0.14 0.33 
Novel -0.02 0.12 -0.78 0.00 0.10 0.34 
Novel -0.69 0.02 -0.76 0.00 -0.17 0.28 
Table 4.5: List of differentially regulated genes and their fold changes for conditions 
satisfied for 1 data set (≥1.5 fold change and p ≤0.05). 
* N denotes missing data due to bad spots. 
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Table 4.6: Differentially regulated genes in mid-exponential phase with >1.5 fold change and p<0.05. 
 Gene Description Function 
    
Protein Metabolism 
Up-regulated Eef1a1 Eukaryotic translation elongation factor 1 alpha 1 Translation elongation 
 16S rRNA rRNA, 16S, mitochondrial Protein biosynthesis 
 Mrpl35 Ribosomal protein L35, mitochondrial Protein biosynthesis 
 Phca Phytoceramidase, alkaline  Protein biosynthesis 
 Rps2 Ribosomal protein S2 Protein biosynthesis 
 Rps27 Ribosomal protein S27 Protein biosynthesis 
 Nedd4 Neural precursor cell expressed, developmentally down-
regulated gene 4 
Ubiquitin cycle 
 Arih1 Ariadne ubiquitin-conjugating enzyme E2 binding protein 
homolog 1 (Drosophila) 
Ubiquitin-dependent protein catabolism 
 Psma4 Proteasome (prosome, macropain) subunit, alpha type 4 Ubiquitin-dependent protein catabolism 
 Ube2a Ubiquitin-conjugating enzyme E2A, RAD6 homolog (S. 
cerevisiae) 
Ubiquitin-dependent protein catabolism 
 Usp10 Ubiquitin specific peptidase 10  Ubiquitin-dependent protein catabolism 
 Psmc5 Peptidase (prosome, macropain) 26S subunit, ATPase 5 Protein catabolism 
Down-regulated Rpl37a Ribosomal protein L37a Protein biosynthesis 
    
Transcription     
Up-regulated 1810007M14Rik RIKEN cDNA 1810007M14 gene Regulation of transcription, DNA-dependent 
 Ubxd2 UBX domain containing 2 Regulation of transcription, DNA-dependent 
 Hmgn3 High mobility group nucleosomal binding domain 3 Positive regulation of transcription 
 Lsm8 LSM8 homolog, U6 small nuclear RNA associated (S. 
cerevisiae) 
Nuclear mRNA splicing, via spliceosome 
 Sfrs5 Splicing factor, arginine/serine-rich 5 (SRp40, HRS) Nuclear mRNA splicing, via spliceosome 
 Yt521 Splicing factor YT521-B Nuclear mRNA splicing, via spliceosome 
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 Gene Description Function 
    
Transcription    
Down-regulated Cstf2t Cleavage stimulation factor 3' pre-RNA subunit 2, tau mRNA processing 
     
Cell Cycle    
Up-regulated Ccng2 Cyclin G2 Regulation of progression through cell cycle 
 Gsg2 Germ cell-specific gene 2 Cell cycle arrest 
Down-regulated Igfbp4 Insulin-like growth factor binding protein 4 Cell proliferation 
 S100a6 S100 calcium binding protein A6 (calcyclin) Cell proliferation 
 Ptma Prothymosin alpha  Regulation of progression through cell cycle 
 Bcl10 B-cell leukemia/lymphoma 10  Induction of apoptosis 
 Rtn4 Reticulon 4 Negative regulation of anti-apoptosis 
    
Signal Transduction 
Up-regulated Mapk6 Mitogen-activated protein kinase 6  Signal transduction 
 Peli1 Pellino 1  Signal transduction 
Down-regulated Gja1 Gap junction protein, alpha 1, 43kDa (connexin 43) Cell-cell signaling 
 Hspa5 Heat shock 70kDa protein 5 (glucose-regulated protein, 
78kDa) 
ER overload response 
 Mpp1 Membrane protein, palmitoylated 1, 55kDa Signal transduction 
    
Transport    
Up-regulated Cox7a2 Cytochrome c oxidase, subunit VIIa 2 Electron transport 
 Fth1 Ferritin heavy chain 1 Iron ion transport 
Down-regulated Atp5g3 ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit c (subunit 9), isoform 3 
Proton Transport 
 Ndufa8 NADH dehydrogenase (ubiquinone) alpha subunit 8, 
19kDA 
Electron transport 
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 Gene Description Function 
 
   
Cytoskeleton    
Up-regulated Anxa2 Annexin A2 Actin cytoskeleton 
 CAP1 CAP, adenylate cyclase-associated protein 1 Cytoskeleton organization and biogenesis 
 Macf1 Microtubule-actin crosslinking factor 1 Microtubule and actin cytoskeleton 
Down-regulated Tmsb10 Thymosin, beta 10 Cytoskeleton organization and biogenesis 
 Tmsb4x Thymosin, beta 4, X chromosome Cytoskeleton organization and biogenesis 
    
DNA Metabolism 
Up-regulated Recql RecQ protein-like DNA repair 
Down-regulated Ercc5 Excision repair cross-complementing rodent repair 
deficiency,complementation group 5 
DNA repair 
    
Lipid Metabolism 
Up-regulated Dci Dodecenoyl-coenzyme A delta isomerase Fatty acid metabolism 
 Elovl5 ELOVL family member 5, elongation of long chain fatty 
acids (yeast) 
Fatty acid elongation 
    
Carbohydrate Metabolism 
Down-regulated Pgm2 Phosphoglucomutase 2 Glucose metabolism 
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4.4 Proteomics analysis 
4.4.1 Overview of protein regulation 
The protein profiles of HP and LP in the mid-exponential growth and stationary 
phases were obtained using the iTRAQ LC-MS technique. Using a similar approach 
to transcriptomic analysis, regulated proteins from each phase were first classified 
into functional groups to obtain an overview of the proteomic profile (Table 4.7 and 
Figure 4.12 for the mid-exponential growth phase, Table 4.8 and Figure 4.13 for the 
stationary phase). Regulated proteins common to both phases were also classified 
(Table 4.8 and Figure 4.14). 
 
Function Up-regulated Down-regulated Total 
Protein metabolism 6 1 7 
Transcription 1 2 3 
Cell Cycle 1 2 3 
Signal Transduction 1 1 2 
Cytoskeleton 1 1 2 
Carbohydrate Metabolism 2 0 2 
Oxidative Stress Response 0 1 1 
Total 12 8 20 
Table 4.7: Overview of differentially regulated proteins in the mid-exponential 
growth phase with >1.2 fold change and 95% confidence. 
 
Function Up-regulated Down-regulated Total 
Protein metabolism 5 1 6 
Oxidative Stress Response 1 4 5 
Carbohydrate Metabolism 3 0 3 
Transcription 1 2 3 
Cell Cycle 1 2 3 
Signal Transduction 0 3 3 
Transport 0 2 2 
Cytoskeleton 1 0 1 
Total 12 14 26 
Table 4.8: Overview of differentially regulated proteins in the stationary phase with 
>1.2 fold change and 95% confidence. 
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Function Up-regulated Down-regulated Total 
Protein metabolism 4 1 5 
Cell Cycle 1 2 3 
Transcription 1 1 2 
Cytoskeleton 1 0 1 
Carbohydrate Metabolism 1 0 1 
Oxidative Stress Response 0 1 1 
Total 8 5 13 
Table 4.9: Overview of commonly regulated proteins for mid-exponential growth 
phase and stationary phase.  
 
Figure 4.12: Proteomic profile of differentially regulated proteins for high producing 
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Figure 4.13: Proteomic profile of differentially regulated proteins for high producing 
cell line in stationary phase. 
 
 
Figure 4.14: Proteomic profile of differentially regulated proteins common to mid-
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Proteomic analysis gave 20 and 26 proteins that satisfied the cut-off criteria 
(>1.2-fold change, 95% confidence) for the mid-exponential and stationary phase 
respectively. Of these proteins, 13 (8 up regulated and 5 down regulated) were 
common to both days. 
As shown in Figure 4.12, the largest number of proteins regulated was in 
protein metabolism (35%), followed by transcription (15%) and cell cycle (15%) in 
the mid-exponential growth phase. These major functional groups concurred with 
those in our microarray findings. This profile also remained unchanged for regulated 
proteins common to both phases (Figure 4.14). However, protein profile in the 
stationary phase had protein metabolism (22%) and oxidative stress response (18%) 
as the two major groups.  
4.4.2 List of differentially regulated proteins 
The observed fold-changes in proteins were small, with a maximum of 2.5 fold and 3 
fold change in the mid-exponential growth phase and stationary phase (Table 4.10 and 
Table 4.11). The lists of differentially regulated proteins in both phases are given in 
Table 4.12 and Table 4.13. Differentially regulated proteins common to both phases 
are listed in Table 4.14. 
From the proteomic data, it was obvious that HP had many proteins up 
regulated in protein biosynthesis and protein folding. This may suggest activity of 
foldases and chaperones in the ER/Golgi that are responsible for the processing of 
proteins. There was also no change detected for key proteins in the UPR pathway 
such as calnexin, Xbp1 and thioredoxins in the mid-exponential growth phase, which 
was consistent with the microarray data. Chromatin modifying proteins were 
identified, which did not appear in the microarray analysis. Protein profile from the 
stationary phase showed a distinct difference between HP and LP with increased 
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carbohydrate metabolism and reduced stress response, where Hspa5 and Txndc5 from 
the UPR pathway and proteins in oxidative stress were down regulated. This may 
indicate higher energy production and a better capacity for protein production in HP.  
 






Up regulated  
Anxa1 24 1.25 1.50 
Anxa2 84 1.61 1.83 
Eef1a1; Eef1a2 64 1.47 1.65 
Eif2S3 2 1.22 1.48 
Hmgb1 16 1.28 1.74 
Hspd1 17 1.23 1.42 
Hyou1 14 1.28 1.81 
Mdh2 11 1.49 1.98 
Nedd4 5 1.32 2.76 
Pkm2 78 1.25 1.40 
Ppib 14 1.26 1.86 
S100a11 8 1.20 1.67 
Down regulated 
Ahnak 32 0.61 0.79 
Basp1 13 0.60 0.82 
Hist1h1c 21 0.53 0.74 
Lgals1 60 0.71 0.81 
Lgals3 13 0.41 0.62 
Mgst1 6 0.42 0.71 
Rpl24 6 0.66 0.72 
Vim 137 0.69 0.75 
Table 4.10: List of differentially regulated proteins in the mid-exponential growth 
phase with HP116:LP114 ratios. 
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Anxa2 84 1.73 2.01 
Eef1a1; Eef1a2 64 1.56 1.80 
Gpd2 13 1.25 1.43 
Hmgb1 15 1.33 1.82 
Hyou1 13 1.47 1.68 
Mdh2 11 1.31 1.73 
Nedd4 5 1.64 3.02 
Pdia3 47 1.23 1.33 
Ppib 14 1.37 1.98 
S100a11 8 1.25 1.69 
Down regulated 
Cav1 5 0.52 0.62 
Cox6b1 7 0.68 0.77 
Dia1 4 0.68 0.81 
Gapd 42 0.70 0.82 
Gstm1 4 0.47 0.70 
Gstm3 4 0.51 0.70 
Hist1h1d 19 0.73 0.82 
Hist1h1c 21 0.73 0.82 
Hspa5 79 0.73 0.81 
Idh1 6 0.46 0.54 
Lgals1 60 0.70 0.82 
Lgals3 13 0.34 0.62 
Mgst1 6 0.46 0.67 
Rpl24 6 0.59 0.74 
Sod1 6 0.62 0.80 
Txndc5 4 0.46 0.82 
Table 4.11: List of differentially regulated proteins in the stationary phase with 
HP117:LP115 ratios. 
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Table 4.12: Differentially regulated proteins in mid-exponential phase with >1.2 fold change and 95% confidence. 
 Protein Description Function 
    
Protein metabolism 
Up-regulated Eif2S3 Eukaryotic translation initiation factor 2 subunit 3 Protein biosynthesis 
 Hspd1 60 kDa heat shock protein, mitochondrial precursor Protein folding 
 Hyou1 Hypoxia up-regulated 1 Protein folding 
 Ppib Peptidyl-prolyl cis-trans isomerase B precursor Protein folding 
 Nedd4 E3 ubiquitin-protein ligase NEDD4 Ubiquitin cycle 
 Eef1a1; Eef1a2 Elongation factor 1-alpha 1 Translation elongation 
Down-regulated Rpl24 60S ribosomal protein L24 Protein biosynthesis 
    
Transcription 
Up-regulated Hmgb1 High mobility group protein 1 Regulation of transcription, DNA-dependant 
Down-regulated Basp1 brain abundant, membrane attached signal protein 1 Regulation of transcription, DNA-dependant 
 Hist1h1c Histone H1.2 Nucleosome assembly 
    
Carbohydrate Metabolism 
Up-regulated Pkm2 Splice Isoform M2 of Pyruvate kinase, isozymes M1/M2 Glycolysis 
 Mdh2 Malate dehydrogenase, mitochondrial precursor Glycolysis 
    
Cell Cycle    
Up-regulated S100a11 Calgizzarin Negative regulation of cell proliferation 
Down-regulated Lgals1 Galectin-1 Regulation of apoptosis 
 Lgals3 Galectin-3 Regulation of apoptosis 
    
Signal Transduction 
Up-regulated Anxa1 Annexin A1 Signal transduction 
Down-regulated Ahnak AHNAK nucleoprotein isoform 1 Intracellular signaling cascade 
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 Protein Description Function 
 
Cytoskeleton 
Up-regulated Anxa2 Annexin A2 Actin cytoskeleton 
Down-regulated Vim Vimentin Cell motility 
    
Oxidative Stress Response 
Down-regulated Mgst1 Microsomal glutathione S-transferase 1 Glutathione metabolism 
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Table 4.13: Differentially regulated proteins in stationary phase with >1.2 fold change and 95% confidence. 
 Protein Description Function 
    
Protein metabolism 
Up-regulated Hyou1 Hypoxia up-regulated 1 Protein folding 
 Ppib Peptidyl-prolyl cis-trans isomerase B precursor Protein folding 
 Pdia3 Protein disulfide isomerase associated 3 Protein folding 
 Eef1a1; Eef1a2 Eukaryotic translation Elongation factor 1 alpha 2 Translation elongation 
 Nedd4 E3 ubiquitin-protein ligase NEDD4 Ubiquitin cycle 
Down-regulated Rpl24 60S ribosomal protein L24 Protein biosynthesis 
    
Transcription 
Up-regulated Hmgb1 High mobility group protein 1 Regulation of transcription 
Down-regulated Hist1h1c Histone H1.2 Nucleosome assembly 
 Hist1h1d Histone 1, H1d Nucleosome assembly 
    
Carbohydrate Metabolism 
Up-regulated Gpd2 Glycerol-3-phosphate dehydrogenase, mitochondrial 
precursor 
Glucose catabolism 
 Gapdh Glyceraldehyde-3-phosphate dehydrogenase Glycolysis 
 Mdh2 Malate dehydrogenase, mitochondrial precursor Glycolysis 
    
Cell Cycle 
Up-regulated S100a11 Calgizzarin Negative regulation of cell proliferation 
Down-regulated Lgals1 Galectin-1 Apoptosis 
 Lgals3 Galectin-3 Cell proliferation 
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 Protein Description Function 
 
Signal Transduction 
Down-regulated Cav1 Caveolin-1 Signal Transduction 
 Hspa5 78 kDa glucose-regulated protein precursor ER overload response 
 Txndc5 Thioredoxin domain-containing protein 5 precursor Response to hypoxia 
    
Transport 
Down-regulated Cox6b1 Cytochrome c oxidase subunit VIb isoform 1 Electron transport 
 Cyb5r3 NADH-cytochrome b5 reductase Electron and iron ion transport 
    
Cytoskeleton 
Up-regulated Anxa2 Annexin A2 Actin cytoskeleton 
    
Oxidative Stress Response 
Up-regulated Idh1 Isocitrate dehydrogenase [NADP] cytoplasmic Glutathione metabolism 
Down-regulated Gstm1 Glutathione S-transferase Mu 1 Glutathione metabolism 
 Gstm3 Glutathione S-transferase Mu-3 Glutathione metabolism 
 Mgst1 Microsomal glutathione S-transferase 1 Glutathione metabolism 
 Sod1 Superoxide dismutase Superoxide metabolism 
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Table 4.14: Differentially regulated proteins in both mid-exponential and stationary phase. 
 Protein Description Function 
    
Protein metabolism 
Up-regulated Hyou1 Hypoxia up-regulated 1 Protein folding 
 Ppib Peptidyl-prolyl cis-trans isomerase B precursor Protein folding 
 Eef1a1; Eef1a2 Elongation factor 1-alpha 1 Translation elongation 
 Nedd4 E3 ubiquitin-protein ligase NEDD4 Ubiquitin cycle 
Down-regulated Rpl24 60S ribosomal protein L24 Protein biosynthesis 
    
Transcription 
Up-regulated Hmgb1 High mobility group protein 1 Regulation of transcription, DNA-dependant 
Down-regulated Hist1h1c Histone H1.2 Nucleosome assembly 
    
Carbohydrate Metabolism 
Up-regulated Mdh2 Malate dehydrogenase, mitochondrial precursor Glycolysis 
    
Cell Cycle    
Up-regulated S100a11 Calgizzarin Negative regulation of cell proliferation 
Down-regulated Lgals1 Galectin-1 Regulation of apoptosis 
 Lgals3 Galectin-3 Regulation of apoptosis 
    
Cytoskeleton    
Up-regulated Anxa2 Annexin A2 Actin cytoskeleton 
    
Oxidative Stress Response 
Down-regulated Mgst1 Microsomal glutathione S-transferase 1 Glutathione metabolism 
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4.5 Comparison of transcriptome and proteome analysis 
Comparing microarray and proteomics data, we found differentially regulated genes 
and proteins fall into the functional classes as shown in Figure 4.15. Overall, there is a 
high degree of consistency between both sets of data with more genes (46) identified 
compared to proteins (20). Although the identified genes and proteins fall into the 
same functional category, we only found 3 genes/proteins (Eef1a1, Nedd4 and Anxa2) 
that were differentially regulated in both protein and microarray data. In other words, 
genes identified by microarray were not identified by iTRAQ and vice versa. This was 
not surprising as mRNA expression does not necessarily correlate to protein 
expression (discussed further in section 5.2). Table 4.15 shows a more detailed 
breakdown of the different type of gene/protein each method identified, showing how 
transcriptome and proteome profiling complements each other. 
Figure 4.15: Distribution of differentially regulated genes and proteins identified by 
microarray and iTRAQ in the mid-exponential phase. 
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Functional Categories Microarray Proteomics 
 
Protein Metabolism 
Protein biosynthesis   
Protein Folding   
Ubiquitin-Proteasome System   
 
Transcription 
Splicing Factors   
Chromatin Modifiers   
Histones   
 
Cell Cycle 
Cell Proliferation   
Apoptosis   
 
Signal Transduction 
Signal transduction   
Cell-cell signalling   
ER response   
 
Transport 
Electron/Proton Transport   
Iron transport   
 
Cytoskeleton 
Actin    
Microtubule   
Cell motility   
 
DNA Metabolism 
DNA repair   
 
Lipid Metabolism 
Fatty acid synthesis   
Fatty acid metabolism   
 
Carbohydrate Metabolism 
Glycolysis   
TCA cycle   
 
Oxidative stress response 
Glutathione metabolism   
Table 4.15: Types of genes and proteins identified by microarray and iTRAQ. 
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4.6 Correlation between gene and protein expression 
Analysis of both datasets yielded only 3 genes/proteins (Eef1a1, Nedd4 and Anxa2) 
that were differentially regulated in both protein and microarray data. This was 
expected as most of the differentially regulated proteins identified have fold changes 
(up regulated HP116:LP114 min < 1.5, down regulated HP116:LP114 > 0.67) that is 
below the cut-off mark for regulated genes of more than 1.5 fold change. Moreover, 
not all proteins have a corresponding gene on the microarray. Further attempts to 
isolate genes/proteins that were commonly regulated gave 9 more genes/proteins as 
shown in Table 4.16 and Table 4.17. 
Microarray Data Proteomics Data  






















Pkm2 0.46 0.00 0.18 0.00 0.10 0.29 1.25 1.40 
Ppib 0.39 0.00 0.08 0.27 0.20 0.05 1.26 1.86 
Down Regulated 
Lgals3 -0.31 0.02 -0.38 0.01 -0.58 0.01 0.41 0.62 
Mgst1 -0.44 0.00 -0.45 0.00 -0.13 0.08 0.42 0.71 
Rpl24 -0.05 0.04 -0.08 0.08 -0.13 0.03 0.66 0.72 
Vim -0.16 0.00 -0.10 0.08 -0.22 0.04 0.69 0.75 
Basp1 -0.45 0.02 -0.36 0.18 -0.18 0.09 0.60 0.82 
Table 4.16: Differentially regulated proteins and their corresponding mRNA 
expression. Only microarray data that has p <0.05 in at least one data set was isolated. 
 
Microarray Data Proteomics Data  






















Anxa2 0.59 0.00 0.39 0.00 0.38 0.03 1.61 1.83 
Eef1a1 1.06 0.00 0.93 0.00 0.86 0.02 1.47 1.65 
Nedd4 0.89 0.00 0.80 0.00 0.47 0.10 1.32 2.76 
Rps2 0.89 0.01 0.69 0.00 -0.03 0.37 0.85 0.99 
Down Regulated 
Hspa5 -1.06 0.00 -0.93 0.01 -0.10 0.23 0.78 0.86 
Table 4.17: Differentially regulated genes and their corresponding protein levels. 
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To investigate the correlation between protein and mRNA levels in the mid-
exponential growth phase, proteins and their corresponding genes in the microarray 
were first identified. Out of 298 proteins identified by iTRAQ, only 66 proteins have a 
corresponding gene on the array. The correlation between global protein levels and 
corresponding mRNA abundance was measured by the Pearson’s method (Appendix 
B). As shown in Figure 4.16, the analysis resulted in a correlation of r = 0.47. 
 
Figure 4.16: Pearson correlation of relative mRNA and protein abundance at mid-
exponential growth phase. 
 
To examine whether this general lack of correlation applies to subsets of 
genes/proteins based on their functions, we applied the Pearson’s method on 
genes/proteins based on their various functional categories (Figure 4.17). The output, 
which is summarized in Table 4.18, shows a strong correlation between protein and 
mRNA levels within certain functional groupings. In particular, carbohydrate 
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metabolism and protein metabolism show strong correlations with r > 0.75, while 
genes/proteins involved in stress response have a correlation of r = 0.67. 
             










































































































r = 0.90 r = 0.56 
r = 0.35 r = 0.78 
r = 0.67 r = 0.23 
r = 0.22 r = 0.07 
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Carbohydrate Metabolism 0.90 5 
Cell Cycle 0.56 10 
Cytoskeleton 0.35 5 
Protein Metabolism 0.78 16 
Response to Stress 0.67 6 
Signal Transduction 0.23 5 
Transcription 0.22 8 
Transport 0.07 7 
Table 4.18: Pearson’s coefficient of relative RNA and protein abundance based on 
their functional groups.  
 
4.7 Real time verification of differentially expressed genes 
Microarray results were validated using quantitative real time polymerase chain 
reaction (QRT-PCR). In 4 out of 5 cases, the results concurred (Figure 4.18). In the 
case of Farslb, microarray shows unchanged gene expression but QRT-PCR detects it 
as down regulated. 
Figure 4.18: Relative QRT-PCR verification of gene expression from microarray 
results.  
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5 DISCUSSION 
In this study, we sought to define the key signatures in the biology of a high 
producing cell line using combined transcriptomic and proteomic analysis. Two 
populations of CHO cells stably expressing high and low levels of green fluorescent 
protein (GFP) were compared using microarray and iTRAQ quantitative protein 
profiling technique. Although there was a general lack of correlation between mRNA 
levels and quantitated protein abundance, results from both datasets concurred on 
groups of proteins/genes based on functional categorization. With this knowledge, we 
can identify potential targets for genetic manipulation as well as design media and cell 
culture parameters to enhance product yield in CHO cells. In addition, a robust 
method of screening clones can be created by printing key genes identified from the 
high producer’s transcriptomic profile on an array. 
5.1 Clone selection 
In 2000, Meng et al described a procedure utilizing GFP as a selectable marker for the 
selection of high producing clones from transfected CHO cells. A dicistronic DHFR 
intron expression vector was used to express vascular endothelial growth factor 
(VEGF) and the selectable marker, dihydrofolate reductase (DHFR), in one 
expression unit and the intracellular GFP in a second expression unit. Transfected 
cells were sorted by FACS and high fluorescent clones were found to produce high 
amounts of the desired protein.     
Based on this strategy, we modified the screening vector to derive two stable 
populations of CHO cells that expressed high and low levels of dhfr-GFP fusion 
protein. The difference in GFP production between high and low producer cells was 
6x, as determined by ELISA. These two populations of CHO cells were grown as 
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detected with significant fold-changes in transcriptomic analysis show different values in 
correlation analysis. 
batch cultures and sampled in the mid-exponential and stationary growth phase for 
comparative microarray and proteomic analysis. 
5.2 Protein and mRNA correlation 
Attempts to correlate protein abundance with mRNA expression levels have had 
variable success. One of the earliest analyses of correlation looked at 19 proteins in the 
human liver where Anderson and Seilhamer (1997) found a somewhat positive 
correlation of r = 0.48. Conversely, Gygi et al (1999b) found that similar mRNA levels 
had protein levels varying by more than 20-fold, and vice versa. In cancer, Chen et al 
(2002) showed a significant correlation in only a small subset of the proteins studied in 
lung adenocarcinomas, while Orntoft et al (2002) found a striking correspondence 
between mRNA and protein levels in human carcinomas.  
In this study, we found a correlation of r = 0.47 for global mRNA and protein 
abundance. On the other hand, when we looked at correlations for each functional 
category, we found strong correlations for carbohydrate metabolism (r=0.90), protein 
metabolism (r=0.78) and stress response (r=0.67). This concurs with findings by 
Greenbaum et al (2002), where they looked at broad categories of genes/proteins - 
groups defined by function, structure, or localization - and found substantial agreement 
between gene expression and protein abundance in yeast. 
However, this data has to be analyzed with caution before we can conclude 
using mRNA levels to predict protein expression for high producers in these categories. 
Although carbohydrate metabolism has the highest correlation, it has a small sample 
number (n=5) and only slight fold-changes (<1.2 fold). Likewise, genes in stress 
response had a small sample number (n=5) and a fold-change of up to 1.41. However, 
genes and proteins in this category showed a down-regulated trend and with this, gene 
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expression in stress response show potential as a predictor of high producer biology.  
In this aspect, predicting high producer biology in protein metabolism using mRNA 
abundance seemed most feasible as genes/proteins in this category showed an up-
regulated trend, a wide range of fold changes of up to 1.81 accompanied by a larger 
sample number (n=16), and a high correlation value. 
Other categories of genes either showed no correlation (transport, r=0.07; 
transcription, r=0.22 and signal transduction, r=0.23) or some correlation (cell cycle, 
r=0.56). In these categories, most genes had only small fold changes (<1.3 fold). In the 
case of cytoskeleton, there was some correlation (r=0.61), but no distinctive up or 
down regulated trends for genes/proteins. 
In general, three factors contribute to the poor correlations generally reported 
in the literature between the level of mRNA and the level of protein, namely (i) 
translational and/or post-translational control of protein expression, (ii) variable 
protein half-lives and (iii) limitations in protein and mRNA experiments due to noise 
and error. 
First, we found that correlation is poor mostly for categories of genes showing 
low fold changes. This implies there could be no difference in gene transcription 
between high and low producer, yet a variation in protein expression takes place since 
the cell can control the levels of protein at the transcriptional level and/or at the 
translational level. Greenbaum et al (2003) compared mRNA and protein abundance 
for open reading frames (ORFs) that had varied or steady levels of mRNA expression 
over the course of the cell cycle in yeast. They found, for ORFs that show a large 
degree of variation in their mRNA levels, protein expression is controlled at the 
transcriptional stage, resulting in a high degree of correlation (r = 0.89) between the 
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reference mRNA and protein levels for these particular ORFs. In contrast, genes 
showing minimal variation in their mRNA levels throughout the cell cycle had protein 
expression controlled at translational and/or post-translational level, giving only 
minimal correlation between protein and mRNA expression for these ORFs (r = 0.2). 
Second, while the timescale of a gene switching event itself is usually short, 
protein turnover can vary significantly, from a few minutes to several days, depending 
on a number of different conditions (Glickman and Ciechanover, 2002). Coupled with 
a possible time displacement from gene activation to protein synthesis and post-
translational processing, the frequency and times of measurement of the transcripts 
and the proteins can affect the modeling of relationships between these variables 
(Nicholson et al, 2004). In our case, we collected samples for mRNA and protein 
quantification simultaneously. Thus, any protein that has a substantial lag-time will not 
coincide with the level of transcript at that instant. 
Last, the choice of method used for quantifying proteins/mRNA can have a 
profound effect on their correlation. In contrast to Gygi et al (1999b), Futcher et al 
(1999) found good correlations between protein and mRNA abundance in yeast, even 
with low abundant proteins. The authors speculated that their method of protein 
quantification by phosphorimaging and image analysis might be more accurate for 
small, weak spots than cutting out spots followed by scintillation counting. RNA 
hybridization data was also used addition to SAGE data, which was helpful for less 
abundant mRNAs. 
Thus, poor correlation of protein to mRNA may be due to the difficulty in 
accurately measuring these non-abundant proteins and mRNAs, rather than indicating 
a truly poor correlation in vivo. 
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Gel-based approaches have their drawbacks, including amount of material 
required, reproducibility, and limits in sensitivity due to protein loss. We used an 
alternative approach to proteomic analysis using iTRAQ peptide labeling followed by 
LC-MS, obtaining an increased sensitivity and quality of mass spectrometric analysis 
on the proteome with few opportunities for sample loss or contamination. Unwin et al 
(2005) have demonstrated that the effectiveness of this system, showing improved 
quantification over conventional systems. However, they were still unable to identify 
the entire proteome; showing that pre-enrichment strategies on the protein sample 
itself is still required to gain quantification on lower abundance proteins.  
In contrast, transcriptome analyses yield more data points with less sample 
required, and no published proteomic study has matched the extent of genomic 
coverage provided by microarrays. Moreover, small changes in mRNA expression are 
routinely detected by microarrays, while subtle changes in protein levels prove to be 
challenging even with current protein methodologies (Chan, 2006). The downside in 
microarray lies in its inability to discern splice variants, whereas proteomics can 
typically detect the proteins encoded by these variants (Hegde, 2003). 
All in all, we found good correlation between mRNA and protein in stress 
response and protein metabolism using our quantification methods. Until advances in 
genomic or proteomic quantification technology prove comprehensive, an integrated 
analysis of the genome and proteome is still required at this point. 
5.3 Signature of high producers 
5.3.1 Protein metabolism is up regulated 
Given that high producing cells are producing more protein product, we expected the 
up regulation of biological processes related to protein metabolism. Most genes 
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associated with protein biosynthesis were upregulated (16S rRNA, Mrpl35, Phca, Rps2 
and Rps27), but 2 large ribosomal subunits, Rpl37a and RPL24 were down regulated. 
Genes/proteins associated with translation (eEF1a1 and eIF2S3) and protein folding 
(Hspd1, Hyou1, Pdia3 and Ppib) were also up regulated. With more protein production, 
genes involved in ubiquitylation (Arih1, Nedd4, Psma4, Psmc5, Ube2a and Usp10) 
were up regulated to degrade misfolded proteins. Interestingly, recent reviews have 
shown the ubiquitin-proteasome system to be involved in processes other than protein 
degradation, which includes transcription, translation, protein refolding and the 
modification of protein activity and function (Muratani and Tansey, 2003; Glickman 
and Ciechanover, 2002; Weissman, 2001). Indeed, when we looked at the list of 
ubiquitylation genes identified, we discovered most of them have been implicated in 
either transcriptional (Psmc5, Ube2a and Nedd4) or translational (Arih1 and Usp10) 
regulation. 
5.3.1.1 Ribosome components 
Ribosome components (16S rRNA, Mrpl35, Rps2 and Rps27) were up regulated in the 
high producer, two of which were mitochondrial (16S rRNA and Mrpl35). The 
eukaryotic ribosome is a multisubunit structure consisting of a (small) 40S subunit, a 
(large) 60S subunit and rRNA (ribosomal RNA). These components fit together and 
work jointly to assemble amino acids into proteins from mRNA (Figure 5.1). This 
indicates more abundant protein synthesis machinery in the high producer. 
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Figure 5.1: The ribosome during protein synthesis. rRNA holds the protein subunits 
together and provides the ribosome with its basic formation and functionality. It 
decodes mRNA into amino acids in the small 40S subunit and interacts with tRNAs 
during translation by providing petidyltransferase activity in the large 60S subunit. 
The 40S and 60S components act as a protein scaffold that enhances the ability of 
rRNA to synthesize protein (Rodnina et al, 2002; Mueller et al, 2000; Cate et al, 1999). 
Source: Frank (2003). 
 
We also observed an interesting phenomenon where the transcripts of the small 
40S subunits (Rps2 and Rps27) were up regulated, while the large 60S subunits 
(Rpl37a and Rpl24) were down regulated. Recent studies gave evidence of 40S and 
60S to be separately assembled in ribosome synthesis and factors known to be 
involved in 60S biogenesis were not found in complexes together with 40S biogenesis 
factors and vice versa (Milkereit et al, 2003; Grandi et al, 2002). Ribosomes are 
generally found in the cytoplasm, but a search on the localization of 40S ribosomal 
units showed Rps27 to be found mainly in the nucleus with DNA binding properties 
(Fernandez-Pol et al, 1993) and Rps2 to have sequences associated with nucleolar 
localization and binding to RNA (Suzuki et al, 1991). There are studies showing the 
association of ribosome components with sites of transcription in the nucleus (Brogna 
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et al, 2002), indicating perhaps, an up-regulation of transcription for high producer 
cells. Deficiency in the 60S subunits was found to have an impact on cell growth 
(Oliver et al, 2004; Tornow and Santangelo, 1994), and this may have contributed to 
the slower growth rate of the high producer.   
5.3.1.2 Translation factors 
The translation initiation factor eIF2 catalyzes the first regulated step of protein 
synthesis initiation by promoting the binding of the initiator Met-tRNA (tRNAiMet) to 
the small ribosomal subunits as a ternary complex of tRNAiMet, Eif2, and GTP (Figure 
5.2). An early analysis on human cDNA encoding eIF2S3 by Gaspar et al (1994) 
suggests its potential for GTP binding, and its strong sequence conservation suggests a 
critical role in the function of eIF-2. Subsequent work by Erickson and Hannig (1996) 
reinforced this view, where they proved eIF2S3 binds to GTP and Met-tRNAiMet in 
eIF-2 and these activities are crucial for eIF-2 function in vivo.  
eEF1a1 is an isoform of the alpha subunit of the elongation factor-1 complex 
which catalyzes the first step of the elongation cycle and is responsible for the 
enzymatic delivery of aminoacyl tRNAs to the ribosome (Moldave, 1985). 
Translational elongation itself does not normally affect the yield or quality of 
polypeptide, but it can become limiting with very high mRNA levels. The bottleneck 
in translation usually lies in the initiation. Since initiation represents the most complex 
aspect of translation, than either elongation or termination, it is not surprising that 
initiation is most often the rate-limiting step of translation (Arava et al, 2003; Gallie, 
2002). In our case, there was an up-regulation of eIF2S3 together with eEF1a1, 
creating the possibility of more efficient translation in the high producer, although not 
for a specific product but an overall increase in protein production. 
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Figure 5.2: Initiation phase of eukaryotic translation. The initiator tRNA is first 
complexed with the active (GTP) form of eIF2 and binds to the 40S ribosomal subunit 
to form the first initiation complex. After this complex is formed, the mRNA is 
positioned with the aid of cap-binding protein (eIF4E) and other eIF4 subunits. Once 
the mRNA is in place, eIF5 mediates the joining of the 60S ribosomal subunit and the 
release of the previous initiation factors. The eIF2, now in its inactive (GDP) form, is 
recycled and reactivated by eIF2B. Source: Gilbert (2003). 
 
5.3.1.3 Protein folding 
After protein synthesis, proteins undergo folding to assume the correct conformation 
for their biological functions. The up regulation of folding proteins in the high 
producer implies the presence of more efficient folding machinery, or simply a 
reflection of increased protein expression.  
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In mammalian cells, the folding of proteins takes place in the protected cellular 
environment of the endoplasmic reticulum (ER). Not only does the ER provide a 
unique folding environment, but it also exerts crucial quality control functions 
(Ellgaard and Helenius 2001). Some proteins require long periods and probably 
undergo many attempts before they attain their final three-dimensional structure. 
Incorrectly or incompletely folded proteins are retained in the ER for refolding or 
degradation by the ER-residing proteasome before they are exported to the 
downstream stations of the secretory apparatus, namely the Golgi compartment. As 
evidenced by the up regulation of folding proteins (Pdia3, Ppib, Hyou1) localized in 
the ER (Ellgaard and Frickel, 2003; Arber et al, 1992; Ikeda et al, 1997), high 
producer cells show more folding activity in the ER as compared to the low producer. 
Hspd1 is localized mainly in the mitochondria (Soltys and Gupta, 1996) and has been 
found to be involved in the folding of DHFR (Gross et al, 1996). Thus, the up 
regulation of Hspd1 could merely be due to the up regulation of DHFR in the high 
producer.  
5.3.1.4 Ubiquitin-proteosome system 
The ubiquitin-proteasome system (UPS) is the primary mechanism in eukaryotic cells 
for degrading unwanted and misfolded proteins. Briefly, the target protein is 
sequentially tagged with ubiquitin monomers to generate the polyubiquitin chain that 
is recognized by the 26S proteasome complex. The 26S proteasome contains a barrel-
shaped proteolytic core complex (the 20S proteasome) capped at one or both ends by 
19S regulatory complexes that recognize the ubiquitinated proteins. Ubiquitinated 
protein targets are then unfolded and translocated by the regulatory complexes into the 
interior of the 20S complex, where they are degraded (Voges et al, 1999) (Figure 5.3).  
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Figure 5.3: The ubiquitin-proteosome system. Source: Donohue (2002). 
 
Ubiquitylation and proteolytic activity is elevated in the high producer, as 
indicated by the up regulation of ubiquitin associated genes (Arih1, Ube2a and Usp10), 
and genes in both the 20S (Psma4) and 19S (Psmc5) proteasome subcomplex. This is 
not surprising, as increased protein production would also generate more misfolded or 
unwanted proteins for degradation. Recent studies have also revealed the involvement 
of the ubiquitin-proteasome system in regulating transcription and translation, and this 
is noteworthy with regards to the high producer’s biology.  
Psmc5/Sug1, one of six AAA-type ATPases that is in the base of the 19S 
proteasome regulatory complex, made its debut as a transcriptional regulator through 
genetic interactions with the yeast transcription activator Gal4 (Swaffield et al, 1992). 
Subsequent biochemical data showed that it interacts with TADs (Transcriptional 
Activation Domain) and general transcription factors TBP and TFIIH, and was found 
in preparations of RNA Polymerase II (Muratani and Tansey, 2003). Work by 
Chapter 5  Discussion 
 86 
Gonzalez et al (2002) further established the involvement of Psmc5/SUG1 in 
transcription. They found that ATPase enzymes of the 19S regulatory complex (but 
not the proteases of the 20S subcomplex) were recruited to the promoter for 
transactivation. In addition, they found Psmc5/SUG1 to associate throughout the entire 
transcribed sequence of the gene, and proposed its role in elongation. 
Unlike Psmc5/Sug1, Ube2a/Rad6 regulates transcription activity through 
chromatin modification. In vitro, Ube2a/Rad6 can attach one or multiple ubiquitin (Ub) 
moieties to histones H2A and B and trigger their E3-dependent degradation. 
Expression of Ube2a in yeast demonstrated preferential localisation of Ube2a in 
euchromatin areas, suggesting that the protein is associated with transcriptionally 
active regions (Koken et al, 1996). In another work by Kao et al (2004), Rad6 and 
ubiquitylated H2B were absent from regions of transcriptionally silent chromatin but 
present at genes that are actively transcribed. Thus, Ube2a/Rad6 directed H2B 
ubiquitylation defines regions of active chromatin. 
Nedd4 proved to be a ubiquitin enzyme with extremely diverse functions. It is 
best characterized by its interactions with the epithelial Na+ channel (ENaC), where it 
regulates channel stability at the plasma membrane through ubiquitination, therefore 
maintaining fluid and electrolyte homeostasis (Ingham et al, 2004). Studies have also 
shown Nedd4 to affect cell cycle by regulating the ubiquitination and stability of 
guanine nucleotide exchange factor CNrasGEF (Pham and Rotin, 2001) and to act in 
association with Grb10 to mediate ligand-dependent ubiquitination of the insulin-like 
growth factor 1 receptor (IGFR-1) (Vecchione et al, 2003). Its involvement in 
transcription regulation lies in the induction of ubiquitin-dependent degradation of the 
transforming growth factor-β (TGF-β) receptor. Kuratomi et al (2005) found 
overexpression of NEDD4 suppresses transcriptional activities induced by the TGF-β 
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superfamily members, whereas silencing of the gene by results in the enhancement of 
signalling by TGF-β.  
Usp10 has also been found to regulate transcriptional activity via 
ubiquitylation of the androgen receptor (AR), thereby regulating stability and 
functionality of AR/associated co-factors. Overexpression of Usp10 enhanced AR 
transcriptional activity whereas knock-down by specific siRNAs had the opposite 
effect (Faus et al, 2005). Besides transcription, Usp10 may also have a possible role in 
translation. A survey on the PABC recognition motif PAM2 identified USP10 as one 
of the proteins carrying this motif (Albrecht and Lengauer, 2004). The PABP 
interacting motif, PAM2, has been identified in various eukaryotic proteins as an 
important binding site for the PABC domain. This domain is contained at the C-
terminus of the poly(A)-binding protein (PABP). In protein synthesis, the PABC 
domain of PABP functions to recruit several translation factors possessing the PABP-
interacting motif 2 (PAM2) to the mRNA poly(A) tail (Kozlov et al, 2004).  
Arih1 was suggested to play a part in translation by Tan et al (2003) when they 
isolated the eukaryotic mRNA cap binding protein, translation initiation factor 4E 
homologous protein (4EHP), as its interacting partner using the yeast 2-hybrid system. 
Both genes were subsequently overexpressed in 293HEKt cells which led to the 
polyubiquitylation of 4EHP by Arih1. Based on preliminary evidence, the authors 
postulated that Arih1-mediated ubiquitylation of 4EHP altered the efficiency of its 
binding to the cap of mRNA, thus promoting translation.  
Suffice to say, the up regulation of these protein metabolism genes in the high 
producer play a role in its protein production and are useful indicators for a high 
producing cell line.   
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5.3.2 Transcription is up regulated 
We found genes for splicing factors (Lsm8, Sfrs5 and Yt521) were up regulated, 
suggesting more efficient mRNA processing in the high producer. In addition, 
genes/enzymes responsible for opening up chromatin (Hmgn3 and Hmgb1) were up 
regulated while enzymes that condense chromatin (Hist1h1c and Hist1h1d) were down 
regulated. This implies the high producer has a more open chromatin structure, leading 
to an enhanced transcription from chromatin templates. 
5.3.2.1 Transcription and splicing factors 
Transcription is the process whereby a messenger RNA (mRNA) template is created 
from a gene sequence in the chromosome template. One way of regulating 
transcription is through transcription factors that bind to the chromosomal DNA at a 
specific promoter, enhancer or suppressor region. While we found up regulation of 
transcription factor genes 1810007M14Rik and Ubxd2, literature on their specific 
functions was unavailable and so we were unable to reach a definitive conclusion. On 
the other hand, although Basp1 was down regulated, it was found to be a 
transcriptional cosuppressor in Wilms’ tumor (Carpenter et al, 2004). Thus, the down 
regulation of Basp1 actually increases transcription activity. 
The up regulation of spliceosomal genes may indicate more efficient mRNA 
processing in the high producer, or due to the increased number of mRNA transcripts, 
since more genes were up regulated in the high producer (refer to Table 4.3). 
Spliceosomes Lsm8, Sfrs5 and Yt521 are involved in the maturation of mRNA 
through the modification of preliminary mRNA (pre-mRNA) by splicing, where 
introns are removed and exons are joined (Kufel et al, 2003; Du and Taub, 1997; 
Rafalska et al, 2004). In the case of Yt521, other than its function as a spliceosome, it 
also participates in the assembly of genes to promote transcription. Nayler et al (2000) 
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found Yt521 localized to YT bodies in the nucleus, which contain focal sites of 
transcription. Yt521 and its molecular binding partners group genes into higher order 
structures of transcription centers, thereby allowing efficient regulation of gene 
expression. 
While other mRNA processing factors were up regulated in the high producer, 
it is interesting to note that transcript levels for Cstf2t, a 3’ mRNA processing factor, is 
down regulated. Cstf2t recognizes GU-rich elements within the 3'-untranslated region 
of eukaryotic mRNAs and is involved in mRNA 3' end processing and transcription 
termination (Deka et al, 2005). In a study by Xing et al (2004), Csft2t complexes with 
heat shock factor 1 (HSF1) in a stress-induced manner. HSF1 recruits polyadenylation 
factors to heat shock protein (HSP) genes and enhances the production 
efficiency/kinetics of mature HSP mRNA transcripts to achieve the critical cellular 
need for rapid HSP expression after stress. Thus, instead of Csft2t being down 
regulated in high producer, it was likely that Csft2t was up regulated in the low 
producer, indicating lower stress present in the high producer (see section 5.3.5). 
5.3.2.2 Chromatin modification 
Chromatin is the structural building block of the chromosome in the nucleus. The state 
of compactness in the chromatin typically dictates the amount of transcription activity 
present. Euchromatin is a lightly packed form of chromatin that is rich in gene 
concentration, and is often under active transcription. The unfolded structure allows 
transcription regulatory proteins and RNA polymerase to bind to the DNA sequence, 
which can then initiate the transcription process. In contrast, heterochromatin is 
chromatin in its condensed form to protect the genes from being transcribed while they 
are not in use. There is therefore a direct link to how productive a cell is with respect 
to the amount of euchromatin that can be found in its nucleus. 
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Figure 5.4: Binding of a transcription factor (TF), such as Hmgb1 and Hmgn3, to the 
nucleosome can destabilize the nucleosome, enable the histones to be removed, and 
open the region for other TFs. Source: Gilbert (2003). 
 
The up regulation of chromatin remodeling enzymes suggests the presence of 
more euchromatin in the high producer. Both Hmgn3 and Hmgb1 bind to nucleosomes 
and promote chromatin unfolding, thus increasing transcription (Ito and Bostin, 2002; 
West et al, 2001; Ueda et al, 2004; Travers, 2003). Nucleosomes are the fundamental 
repeating subunits of the chromosome, consisting of a DNA chain coiled around a 
histone core and is involved in the regulation of transcription by preventing RNA 
polymerase from accessing genes which are not required by the cell. When the 
requirements of the cell change, chromatin remodeling enzymes can remove or change 
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the position of the nucleosome to allow access to the transcription machinery. The 
down regulation of histone 1 proteins, Hist1h1c and Hist1h1d, also indicates a more 
open chromatin structure in the high producer. Unlike histones that make up the 
histone core in the nucleosome, histone 1 acts as linker between the DNA and the 
histone core, which explains why other histone proteins were not down-regulated. In a 
work by Ogawa et al (1995), they showed that over expression of Hmgb1 in cells 
showed a concomitant decrease of histone 1 proteins with an enhanced expression of 
their reporter gene, thus establishing a relationship between the amounts of Hmgb1 
enzymes and the linker histone 1.  
5.3.3 Cell growth is decreased 
In our study, cell cycle genes and proteins that promote cell growth (Igfbp4, Ptma, 
S100a6) were down regulated while those that deter cell growth (Ccng2, Gsg2 and 
S100a11) were up regulated. This agrees with the growth kinetics of our high producer 
cells in comparison to the low producer cells. At this juncture, we cannot conclude that 
these genes and proteins are only involved in regulating cell growth without a part in 
increasing protein product synthesis. It is highly possible that with cell arrest, cells put 
all their energy into protein production, hence increasing product yield. This coincides 
with a study by Takahashi et al (1994) where they showed that growth rate 
suppression of cultured mammalian cells enhanced protein productivity, and in another 
study by Takagi et al (2001), where there was an inverse correlation between the 
specific rates of CHO cell growth and tPA production. In a more recent study by Yoon 
et al (2006), the authors investigated the effect of cell growth and recombinant protein 
production under hypothermic conditions. Culturing cells at low culture temperatures 
(32oC) improves the specific productivity of cells but compromised cell growth, which 
results in low volumetric productivity. In an attempt to increase volumetric 
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productivity, the authors improved the growth rate of cells under hypothermic 
conditions. This method, however, caused a decrease in the specific productivity. Thus, 
we can see that growth rate can actually affect the cell’s protein production. 
We also noticed a down-regulation of genes/proteins regulating apoptosis 
(Bcl10, Rtn4, Lgals1 and Lgals3). Bcl10 has been shown to be involved in the 
induction of apoptosis (Willis et al, 1999) while Rtn4 is a negative regulator of anti-
apoptosis through its interaction with Bcl-XL and Bcl-2 and reduces their anti-
apoptotic activity (Tagami et al, 2000). Lgals1 and Lgals3 turned out to be bi-
functional, either inducing or inhibiting apoptosis depending on the surrounding 
conditions (Scott and Weinberg, 2004; Nakahara et al, 2005). The strategy using 
apoptosis inhibition in cell cultures to improve product yield has undergone extensive 
research and is applied in the biotechnology industry today (Arden and Betenbaugh, 
2004a). In a study by Mazur et al (1998), extended growth arrest of CHO cells 
deficient in apoptotic but not cell-cycle arrest function was accompanied by a 10 to15-
fold increase in their production. Whether the increased productivity of the high 
producer is attributed to the down regulation of apoptosis remains to be elucidated, as 
we did not see an improved cell viability of the high producer over the low producer. 
5.3.4 Cytoskeleton: actin and microtubule turnover is up regulated 
The cytoskeleton within a cell is a protein framework made up of actin filaments, 
intermediate filaments and microtubules, and is mainly responsible for the cell’s shape, 
internal spatial organization, and motility. Besides that, the cytoskeleton has also been 
implicated in protein synthesis. Hesketh (1994) showed critical evidence that 
polyribosomes, mRNAs and components of the protein synthetic machinery are 
associated with the cytoskeleton in eukaryotic cells. Most of his evidence suggests that 
polyribosomes interact with the actin filaments and the cytoskeleton is involved in the 
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transport and localization of RNA. Since mRNAs act as templates for translation, their 
localization allows specific proteins to be synthesized in the subcellular regions where 
they are required, and prevents their expression in regions where they are not. In 
principle, localized protein synthesis seemed to be a very efficient way to target 
proteins to the correct sites, as presumably more energy is needed to localize many 
protein molecules than a single mRNA that can be translated multiple times (St 
Johnston, 1995). 
From our data, we found genes involved in actin and microtubule turnover to 
be up regulated (Anxa2, Cap1 and Macf1). Various studies showed eEF1a1 to interact 
with cytoskeleton components like tubulin and actin (Condeelis, 1995) and interaction 
of eEF1a1 with actin may regulate its activity or its availability in protein synthesis 
(Stapulionis et al, 1997). In addition to eEF1a1, other protein synthesis components 
such as eIF2 and ribosomes have been observed to associate with the cytoskeleton 
(Howe and Hershey, 1984), and the transport and localization of mRNA by 
microtubules has also been well documented (St Johnston, 1995; Fusco et al, 2003). 
Taken together, the up regulation of all these genes/proteins, as well as overall mRNA, 
suggests more localized protein synthesis occurring in the high producer. 
5.3.5 Stress response is down regulated 
From combined microarray and protein data, we found signs of reduced ER and 
oxidative stress in the high producer as compared to the low producer. Cell perception 
of ER stress causes the attenuation of mRNA translation through the inactivation of 
eIF2α, leading to a shut down of global protein synthesis (Underhill et al, 2005). 
During oxidative stress, the cell’s initial response will activate its defense mechanism 
by altering the expression of anti-oxidant genes to attempt cell rescue. Once beyond 
the threshold however, apoptosis is elicited by the release of pro-apoptotic proteins 
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(Lee and Wei, 2005). Thus, the implications of reduced stress in high producers are 
two-fold: cells are less likely to undergo apoptosis, and the cell’s energy will not be 
diverted from producing the required protein product, leading to higher product yield. 
5.3.5.1 ER stress response 
Key genes/proteins in the UPR (unfolded protein response) pathway: PERK, ATF6, 
Xbp1, calnexin, calreticulin, GRP94, HSP chaperones and ERp foldases (Schroder and 
Kaufman, 2005) did not show significant differential expression, except for 
Hspa5/BIP/GRP78, which was down regulated in the high producer. Hspa5 is a major 
endoplasmic reticulum (ER) molecular chaperone gene implicated in ER overload 
response (Laitusis et al, 1999; Brostrom et al, 1995). It has the ability to control the 
activation of transmembrane ER stress sensors (IRE1, PERK and ATF6) and its 
specific induction is indicative of ER stress. This lead to the measurement of Hspa5 
transcript levels as a monitor of endoplasmic reticulum stress (Lee, 2005). From our 
data, Hspa5 was transcriptionally down regulated in the mid-exponential phase and its 
protein level was down regulated in the stationary phase for the high producer. This 
suggests that protein folding is within the cell’s capacity and not over burdened, 
corresponding to more efficient protein folding in high producer cells.  
5.3.5.2 Oxidative stress response 
Reduced oxidative stress response in the high producer cells was indicated by the 
down regulation of Sod1, Gstm1, Gstm3 and Mgst1. Sod1 and enzymes in glutathione 
metabolism (Gstm1, Gstm3 and Mgst1) have been found to be up regulated in 
response to oxidative stress (Scandalios, 2005). Sod1 is a metalloprotein that binds 
copper and zinc ions and is the responsible for the initial destruction of free superoxide 
radicals in cells (Perez and Cederbaum, 2003). Glutathione S-transferases Gstm1 and 
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Gstm3 function in the detoxification of electrophilic compounds such as 
environmental toxins and products of oxidative stress, by conjugation with glutathione 
(Nebert and Vasiliou, 2004) while Mgst1 acts as a sensor of oxidative stress and is up 
regulated during oxidative stress to provide cellular and organelle protection 
(Busenlehner et al, 2004; Morgenstern, 2005). 
The up regulation of cytoplasmic Idh1 on the other hand, modulates oxidative 
damage in the high producer cells. Idh1 serves a significant role in cytoplasmic 
NADPH production, which is essential in the regeneration of reduced glutathione. Lee 
et al (2002) found that, with the same levels of all other antioxidant enzymes, cells 
with lower levels of Idh1 became more sensitive to oxidative damage while the cells 
with the highly over-expressed Idh1 exhibited enhanced resistance against oxidative 
stress, as compared to the control cells. In addition, we also found the up regulation of 
Fth1, which has also been implicated as a possible attenuator of the oxidative stress 
response (Epsztejn et al, 1999). 
Within the cell, there is a delicate balance between the production of reactive 
oxygen species (ROS) and antioxidants, and oxidative stress occurs when there is an 
overabundance of ROS. The mitochondria is strongly involved in production of ROS 
and the cycle of oxidative stress and damage to cellular structures can lead to either 
cell death by apoptosis or to a cellular energy decline (Lenaz et al, 1999). Thus, 
reduced oxidative stress in the high producer may be linked to the down regulation of 
apoptotic genes/proteins (section 5.3.3) as compared to the low producer. 
5.3.6 Energy generation 
Mammalian cells generate energy through cellular respiration where energy released 
by the breakdown of fuel molecules is transferred to ATP. Interestingly, we found Dci 
in fatty acid metabolism and proteins involved in carbohydrate metabolism, such as 
Chapter 5  Discussion 
 96 
glycolysis enzymes (Gapdh, Pkm2 and Gpd2) and Mdh2, to be up regulated in the 
high producer, but genes and proteins (Cox6b1, Ndufa8 and Atp5g3) in oxidative 
phosphorylation were down regulated, except for Cox7a. This seemed to point towards 
more energy generation through lipid and carbohydrate metabolism in high producer 
cell with lower activity in oxidative phosphorylation.  
 
5.3.6.1 Lipid and carbohydrate metabolism are up regulated 
Energy comes from the degradation of either fats or carbohydrates through oxidation, 
with fats yielding 2 to 3 times more energy than carbohydrates. The pathway by which 
fats are degraded is called beta-oxidation while the break down of carbohydrates 
occurs mainly through pathways of glycolysis and the citric acid cycle (Krebs' cycle). 
A key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids, 
Dci catalyzes the transformation of 3-cis and 3-trans intermediates that arise during the 
stepwise degradation of all cis-, mono-, and polyunsaturated fatty acids into 2-trans-
enoyl-CoA intermediates (Janssen et al, 1994). Oxidation of 2-trans-enoyl-CoA can 
then proceed to completion, providing acetyl-CoA that is subsequently channeled into 
the citric acid cycle to further contribute to the cell's energy supply. Thus, Dci up 
regulation suggests more energy generated from the beta-oxidation pathway. 
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) is a glycolytic enzyme 
that is involved in cellular energy production and has important housekeeping 
functions. A recent study by Sukhanov et al (2006) showed a potential link between 
oxidative stress and Gapdh activity. Oxidized low-density lipoprotein (OxLDL), a 
natural prooxidant, was used to induce oxidative stress in smooth muscle cells. 
OxLDL rapidly elevated H2O2 levels and oxidized Gapdh thiols, decreasing Gapdh 
protein half-life and its sensitivity to proteasome-mediated protein degradation in vitro, 
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resulting in marked depletion of cellular ATP levels. The authors also found small 
interfering RNA-specific (siRNA) down regulation of Gapdh caused in a reduction in 
glycolysis rate and decrease in ATP levels. Thus, the reduced oxidative stress in the 
high producer may have contributed to the higher levels of Gapdh and hence allowed 
more energy production through glycolysis. 
Pyruvate kinase (Pkm2) catalyses the final step of the glycolytic pathway, and 
is one of the three steps in glycolysis that regulate the overall activity of the pathway 
(Berg et al, 2002). Mazurek et al (2002) found the Pkm2 isoenzyme to switch between 
a less active dimeric form and a highly active tetrameric form which regulates the 
channeling of glucose carbons either to synthetic processes (dimeric form) or to 
glycolytic energy production (tetrameric form). Tumor cells are usually characterized 
by a high amount of the dimeric form, leading to high cell proliferation rates and a 
strong accumulation of all glycolytic phosphometabolites above pyruvate kinase. The 
up regulation of Pkm2, coupled with the slower growth rate of the high producer, 
indicates a possible increase in glycolytic energy production. 
Mitochondrial glycerophosphate dehydrogenase (Gpd2) acts together with the 
cytoplasmic NAD-linked glycerophosphate dehydrogenase (Gpd1) to form the 
glycerophosphate shuttle which participates in the reoxidation of cytosolic NADH by 
delivering reducing equivalents from this molecule into the electron transport chain, 
thus sustaining glycolysis. The activity of Gpd2 is low in most mammalian tissues but 
active in cancer tissues that have elevated rates of glycolysis (MacDonald et al, 1990). 
A more recent study by Chowdhury et al (2005) showed that the significant elevation 
of Gpd2 abundance and activity, but not Gpd1, was involved in maintaining a high 
rate of glycolysis in prostate cancer cell lines. Although Gpd2 acts as an ROS 
generator in cancer cells, the authors found that this was not the case in normal cells. 
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Thus, it is probable that the up regulation of Gpd2 increases glycolytic activity in the 
high producer without elevating ROS. 
Malate dehydrogenase (Mdh2) catalyzes the conversion of malate into 
oxaloacetate, and is involved in several carbohydrate metabolism pathways, namely 
the citric acid cycle, pyruvate metabolism and glyoxylate and dicarboxylate 
metabolism (KEGG Pathway database). Thus, up regulation of Mdh2 in the high 
producer could be a sign of increased carbohydrate metabolism in general. 
5.3.6.2 Balanced oxidative phosphorylation 
Oxidative phosphorylation (OXPHOS) takes place within the mitochondria, and is the 
final metabolic pathway of cellular respiration after glycolysis and the citric acid cycle. 
We found a general down regulation of OXPHOS genes and proteins (Cox6b1, Ndufa8 
and Atp5g3) in the high producer, indicating a less active mitochondrial respiratory 
system compared to the low producer. 
Under normal conditions, generation of ATP through oxidative 
phosphorylation is an efficient and preferred metabolic process, since far more ATP 
molecules are produced from a given amount of glucose as compared with glycolysis. 
However, when the ability of cells to generate ATP through mitochondrial oxidative 
phosphorylation is compromised, cells are able to adapt alternative metabolic 
pathways, such as increasing glycolytic activity, to maintain their energy supply.  This 
is known as the Warburg effect and is a phenomenon observed in many cancer types 
(Xu et al, 2005). The underlying mechanisms responsible for the Warburg effect have 
been controversial, but most studies attributed this effect mainly to mitochondrial 
defects and hypoxia (Zu and Guppy, 2004). At first glance, the high producer’s profile 
of increased glycolysis and reduced OXPHOS activity seemed to satisfy the Warburg 
effect. However, mitochondrial dysfunction is often accompanied by elevated levels of 
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oxidative stress (Pelicano et al, 2004; Hileman et al, 2004), which did not occur in the 
high producer. Instead, it was the low producer that showed signs of elevated oxidative 
stress. This led us to postulate that it was the low producer that has an up regulation of 
OXPHOS activity, rather than the down regulation of OXPHOS activity in the high 
producer. 
Figure 5.5: Depiction of the electron-transport chain showing the sites of production of 
reactive oxygen species (O2•-). Source: Chen et al (2003). 
 
During oxidative phosphorylation, premature electron leakage from electron 
transport complexes occurs as electrons are transported through the respiratory chain, 
generating reactive oxygen radicals (Wei, 1998). Early studies have identified 
complex I and complex III as the major sites for ROS production (Sugioka et al, 1988; 
Turrens and Boveris, 1980) but recently, Chen et al (2003) showed complex III as the 
principal site for ROS release from mitochondria. Unlike complex I, which directs the 
release of ROS towards the mitochondrial matrix antioxidant defenses, complex III 
releases ROS toward the intermembrane space away from matrix antioxidant defenses, 
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thus favoring ROS release from mitochondria (Figure 5.5). By inhibiting Complex I 
with rotenone, Chen et al also showed that limiting electron flow upstream of complex 
III minimized ROS generation during the oxidation of complex I substrates. The up 
regulation of Ndufa8 in the low producer suggests an increased activity in complex I 
only. This causes a surge in electron flow from complex I, thereby generating more 
ROS from complex III and elicits an oxidative response in the low producer (see 
section 5.3.5.2). Thus, we see the key to generating more energy through the electron 
transport chain system requires a coordinated up regulation of all complex components.  
5.3.6.3 Increase in mitochondrial abundance 
We found a general up regulation of mitochondrial proteins and mitochondrial 
biogenesis genes in the high producer, indicating perhaps, more mitochondria (Table 
5.1). Out of 11 mitochondrial components identified, 7 were up regulated. Looking at 
their respective fold changes, we also observed a more significant fold change in the 
up regulated components as compared to those down regulated. 
 Gene/Protein Fold Change 
Up regulated 16S rRNA 2.64 
 Mrpl35 1.51 
 Cox7a2 1.91 
 Dci 1.59 
 Gpd2 1.25 
 Mdh2 1.49 
 Hspd1 1.23 
   
Down regulated Ndufa8 1.52 
 Atp5g3 1.55 
 Mgst1 1.41 
 Cox6b1 1.30 
Table 5.1: List of differentially regulated mitochondrial genes and proteins in high 
producer. 
 
The principal function of mitochondria is to synthesize ATP through electron 
transport and oxidative phosphorylation (OXPHOS) in conjunction with the oxidation 
of metabolites by citric acid acid cycle and catabolism of fatty acids by β-oxidation. 
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Mitochondrial content is often a reflection energy production with high densities in the 
muscles of extreme aerobic athletes such as antelopes (Lindstedt et al, 1991), tuna 
(Moyes et al, 1992), hummingbirds and insects (Wells and Ellington, 1994). Even the 
mitochondrial content of homologous muscles varies widely between similar species 
in relation to body size and activity levels, with athletic species possessing higher 
levels of mitochondria than sedentary species (Moyes, 2003). Thus, having larger 
numbers of mitochondria improves the production capacity of the high producer for 
increased protein metabolism. 
Alternatively, higher numbers of mitochondria serve to create an efficient and 
balanced bioenergetics to reduce oxidative stress and attenuate age-dependent 
endogenous oxidative damage experienced by the cell. Lopez-Lluch et al (2006) found 
calorie restriction in rat and human cells reduced oxidative stress at the same time that 
it stimulated the proliferation of mitochondria. This larger amount of low-potential 
mitochondria was able to maintain a balanced respiratory chain activity fully capable 
of handling reduced oxygen consumption while maintaining ATP synthesis but with a 
lower ROS production. This concurs with the profile of our high producer, where 
increased abundance of mitochondria corresponds to decreased oxidative stress 
response. 
5.3.6.4 Choice of metabolic pathways and energy distribution 
As mentioned previously, cells are able to choose between glycolysis and oxidative 
phosphorylation pathways for ATP generation. Most cells utilize the mitochondrial 
OXPHOS pathway during aerobic respiration, as it gives a much higher ATP yield. 
However, ROS generated during this process can prove detrimental to the cells, 
leading to oxidative stress and apoptosis. Nevertheless, with an efficient and balanced 
electron chain transport system, it is still possible to efficiently generate high amounts 
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of energy through the OXPHOS system with low mitochondrial rate of oxygen radical 
production, as shown in bird mitochondria (Barja, 1998).  
On the other hand, increasing aerobic glycolysis can offer protection against 
oxidative stress, albeit at the expense of energy yield. Pyruvate is an effective 
scavenger of ROS and this is an alternative strategy for proliferating cells to minimize 
oxidative stress during the phases of the cell cycle when maximally enhanced 
biosynthesis and cell division occurs (Brand, 1997). A shift towards the glycolytic 
pathway was observed in murine hybridoma grown in serum-free medium in 
continuous culture at high dissolved oxygen concentrations (Jan et al, 1997), showing 
the versatility of cells in choosing metabolic pathways to reduce oxidative stress. This 
concurs with our observations in the high producer’s profile where increased 
glycolysis corresponds to decreased oxidative stress (Section 5.3.5.2). 
Energy distribution is yet another factor that affects recombinant protein yield. 
With faster growth rates in the low producer over the high producer, it is highly 
probable that more energy generated in the low producer is channeled to cell growth. 
Several studies have shown that inhibition of ATP production through OXPHOS 
reduced cell proliferation, and in some cases, caused complete growth arrest (Nagiec et 
al, 2005; Jazayeri et al, 2003; Kroll et al, 1983). In these studies, the loss in OXPHOS 
activity was accompanied by the increase in glycolysis, but not cell growth. Thus, it is 
highly probable that under normal conditions, increase in energy production through 
OXPHOS is channeled to cell growth. With growth inhibition however, another 
scenario takes place.  
Growth arrest, per se, does not lead to the improvement of recombinant 
production, as shown by Carvalhal et al (2003a) when they induced growth arrest in 
CHO cells producing SEAP (secreted alkaline phosphotase) using nucleotides, 
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nucleosides and bases (Nt/Ns/B). Although both adenine and guanine Nt/Ns/B induced 
growth arrest, only adenine Nt/Ns/B improved SEAP productivity by 3-fold. A further 
investigation showed growth arrest with adenine Nt/Ns/B was accompanied by an 
increase in cell metabolism, with rates of glutamine/glucose consumption and 
lactate/ammonia production being 2 to 3-fold higher than in the control. On the other 
hand, addition of guanine Nt/Ns/B did not alter the cell metabolism. Thus, increase in 
recombinant protein production through growth inhibition is possible only when there 
is a complementary increase in cellular metabolism. In a subsequent study by 
Carvalhal et al (2003b), the authors showed that p27 overexpression induced growth 
arrest in CHO cells producing SEAP with a 4-fold increase in SEAP productivity.  A 
general 2-fold increase in oxygen, glutamine and glucose consumption rates, coupled 
with an increase in lactate and ammonia production was observed after growth arrest; 
along with a significant increase in the intracellular pool of AMP (8.5-fold), ADP (6-
fold) and, ATP (4.5-fold). Nevertheless, the cells were able to maintain equilibrium 
among the three adenine nucleotides as both the ATP/ADP ratio and the energy charge 
values remained similar to those observed with non-growth inhibited cells. This work 
showed that increase in recombinant protein productivity after cell growth inhibition 
by p27 occurred concomitantly with a higher expenditure of cell energy. This 
phenomenon is further evidenced in a study by Bi et al (2004), where the uncoupling 
of cell proliferation resulted in an enhancement of productivity in p21CIP1-arrested 
CHO cells, accompanied by significant increases in mitochondrial mass and 
mitochondrial activity.  
Thus, we can conclude that the balance and distribution of energy is one of the 
key factors in high levels of recombinant protein production.  
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5.3.7 Summary 
The changes found in the various functional gene and protein groups of a high 
producer are summarized in Figure 5.6. The three major groups of differentially 
regulated genes are protein metabolism (25%), transcription (15%) and cell cycle 
(13%). Carbohydrate and lipid metabolism also form a significant percentage (11%), 
showing that energy production plays a part in high producer biology.   
Figure 5.6: Distribution of functional gene and protein groups differentially expressed 
in the high producer. This pie chart shows the combined data from the transcriptome 
and proteome profiling in both mid-exponential and stationary growth phase. 
 
The essential cellular processes, together with the regulation of their respective 
genes and proteins, are represented in Figure 5.7. Up regulated genes/proteins, 
increased energy flux or processes are denoted in red. Likewise, down regulated 
genes/proteins, decreased energy flux or processes are denoted in blue. 
High producers have increased energy production through the up regulation of 
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distributed amongst various cellular processes with more energy channeled to cellular 
processes with high activity.  
Decrease in cell proliferation genes/proteins impedes cell growth rate reduces 
energy required in this process. This allows more energy to be channeled to the high 
producer cell’s protein synthesis machinery consisting of transcription, translation and 
cytoskeleton elements. Transcription activity is increased, through the opening of 
chromatin via chromatin modifiers coupled with a reduction in histone abundance and 
through an improvement in mRNA processing by the elevated expression of splicing 
factors. The efficacy in protein processing is increased through elevated levels of 
translation factors, ribosomes, protein foldases, ubiquitin and proteasome enzymes. 
Finally, up regulation of cytoskeletal components, actin and microtubles, serve to 
improve mRNA transport and localized protein synthesis within the cell.  
The apparent low level in stress response is also of notable interest in the high 
producer biology. Oxidative stress is attenuated when there is less production of 
reactive oxidative species (ROS). This is accomplished through the increase in 
glycolytic activity and mitochondrial abundance. Reduction of ROS reduces 
mitochondrial dysfunction and apoptosis, thus preventing energy depletion and cell 
death. The lack of ER stress is due to the high amounts of protein foldases that allows  
efficient protein processing and an adequate ubiquitin-proteasome system that prevents 
protein build up in the ER. Prevention of ER stress is important as it can lead to a 
global shut down of the protein translation system in the cell, thus putting a halt to all 
protein biosynthesis until ER stress is alleviated. Furthermore, any stress response 
would divert the cell’s energy into its defense mechanism, and reduce recombinant 
protein production. 
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 With all these elements in place, the cell is well primed to handle the high production 
of recombinant proteins. 
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Energy Distribution
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5.4 High throughput screening for high producer cells 
5.4.1 Genetic manipulation of host cells 
 By improving the innate ability of host cells to produce large amounts of recombinant 
protein, we will be able to cut down the number of clone screening as ideally, each 
transfected cell resembles a high producer except for the integration site. From our 
results, we saw that improving protein production lies not in the over expression of 
one or few genes, but instead, involves the orchestration of several cellular processes.  
To generate a high producing cell line, one or several genes from each cellular 
process can be chosen for overexpression in the host cell. These genes can be tagged 
with a fluorescent marker to enable FACS sorting during protein expression. With the 
wide array of fluorescent proteins available today, multiple genes can be labeled, 
transfected and screened simultaneously (Shaner et al, 2005). Since fluorescence 
intensity corresponds to the amount of protein produced, the right combinations of 
genes along with the appropriate level of expression can be sorted using FACS. Table 
5.2 lists a possible combination of genes for cell line engineering. In addition, genes 
encoding enymes that improve the productivity specifically for the desired 
recombinant proteins can also be added. For example, the cloning of α-2,3-
















Energy Generation Glycolysis Pkm2  
 Mitochondrial Abundance PGC-1α1 
Protein Metabolism Protein Biosynthesis Eef1a1 
 Protein Folding Ppib 
 Ubiquitin Proteasome System Nedd4 
Transcription Splicing Factors Yt521 
 Chromatin Modifier Hmgn3 
Cytoskeleton Actin cytoskeleton 
 
Anxa2 
Table 5.2: Genes overexpressed in the host cell for the creation of a high producer. 
 
1The upregulation in the expression of PGC-1α has been shown to increase 
mitochondria proliferation (Lee and Wei, 2005). 
5.4.2 High throughput screening using arrays 
After genetically modified cell clones have been sorted, a cDNA microarray tailored 
for screening high producer clones can be used to further screen for clones with the 
required signature. The potential arrangement for the microarray is shown in Figure 
5.8, along with the desired profile. 
Figure 5.8: cDNA microarray for screening high producer cells. High producer clones 
(Cy5) are compared against the parental cell line (Cy3). cDNA on the microarray are 
arranged such that an obvious pattern will emerge after hybridization. Red: up 
regulated in high producer. Green: down regulated in high producer. Yellow : no 
change. 
Protein Metabolism (Protein Biosynthesis, Protein folding, Ubiquitin-
Proteasome system) 
Transcription (Splicing Factors, Chromatin modifiers) 
Energy Production (Mitochondrial, Carbohydrate and Lipid Metabolism, 
Glycolysis, Kreb’s Cycle, OXPHOS) 
Cytoskeleton (Actin, Microtubules) 




Cell Cycle (Growth arrest) 
Others (reduce stress response, recombinant protein)  
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In addition, to cut down the number of potential high producer clones for 
microarray analysis, an initial screening of all the sorted clones can be performed with 
a clone array. Total RNA is first extracted from each clone and the cDNA synthesized. 
Equal amounts of cDNA from these clones can then be spotted on a surface (e.g. 
membrane or glass), creating an array of all the selected clones. Since we are looking 
for an up or down regulation of a cellular process, and not any gene in particular, a 
group of expressed sequenced tag (EST) probes representing one cellular process can 
be labeled with the same fluorophore and hybridized onto this high producer clone 
array (Figure 5.9). For example, EST from initiation factors, translation factors and 
ribosomes can be pooled together to represent protein biosynthesis. Depending on the 
desired expression, spots with high or low intensities can be singled out as potential 
high producers, followed by a detailed analysis using the high producer cDNA 
microarray (Figure 5.8). This process can be replicated using a multiplex RT-PCR, 
where the primer mix contains primers priming the EST portions of genes representing 
a cellular process. The final choice on process application will depend largely on the 
accessibility and cost effectiveness of each method. 
Figure 5.9: Screening for high producer clones using a clone array. A group of labeled 
probes representing a cellular process, in this case protein biosynthesis, is hybridized 
onto the clone array. Spots with high intensity will indicate clones having high activity 
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5.4.3 Validation of host cell line and process optimization 
Since a high producing host possesses the cellular machinery for high production, 
transient transfection of the host cell line can be performed to validate the suitability of 
the host cell line for a particular protein product. During protein production, initial 
process variables will be designed based on the microarray data obtained during clone 
screening. Subsequently, gene expression of the cell can be also be monitored using 
the high producer microarray chip for further process optimization. Quantification of 
selected proteins, such as protein foldases, histones and enzymes in the glutathione 
pathway (for oxidative stress response), can be added as our results showed that 
expression of these proteins were not detected at the transcriptional level. 
Consequently, instead of taking shots in the dark, a more focused and efficient method 
of optimization is achieved, reducing both cost and time during process optimization 
in recombinant protein production. Figure 5.10 shows a summary for the process of 
high throughput selection for a high producer.  
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Figure 5.10: High throughput screening for improved recombinant protein production.




6.1.1 Key signature of a high producer 
Our profiling experiments reveal the following signature for high producers: 
• Increased energy generation through lipid and carbohydrate metabolism, with 
more abundant mitochondria.  
• Decreased cell proliferation and reduced apoptosis. 
• Increased activity in processes related to protein biosynthesis such as transcription, 
translation, protein folding and protein degradation. 
• Reduced stress response for ER and oxidative stress. 
From our results, we did not detect any genes/proteins with drastic changes in their 
expression levels. Instead, we only found differential expressions of up to 3-fold in a 
wide array of genes/proteins involved in various cellular processes. Thus, we conclude 
that the key to improving protein production lies not in the over expression of one or 
few genes, but instead, involves the orchestration of several cellular processes. The 
balance and distribution of energy, together with increased activity in protein 
biosynthesis and the reduction of cellular stress, all play a part in high protein 
production.  
6.1.2 Effective integration of genomics and proteomics platform 
In this study, we showed that an integrated approach using microarray and iTRAQ 
protein profiling can be effectively utilized as tools to monitor global transcriptional 
and post-transcriptional events of mammalian cells in culture. These observations 
provided us with valuable insights into the changes occurring in the cells as a result of 
recombinant protein expression, and allowed us to rationally engineer cell-lines with 
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enhanced productivity as well as optimize media design and cell culture processes 
leading to improved productivity in CHO cells. 
6.2 Future recommendations 
6.2.1 Improving correspondence between microarray and proteomics 
data  
Due to a lack of identified CHO genes and protein in the public database, we found a 
disparity in the annotation of genes and proteins for their respective database. Genes 
were annotated based on their similarities to the available CHO, mouse, human and rat 
sequences in the NCBI nucleotide database; while the proteins were identified based 
on the mouse, rat and human sub-sets of the IPI protein database (version 3.13). This 
created some difficulty during the correlation of mRNA and protein abundance as 
many proteins did not have a corresponding gene on the array and vice versa. With the 
proven effectiveness of integrated microarray and proteomics as a tool to monitor and 
elucidate cellular events during culture, an improved correspondence between these 
databases will streamline the analysis process in future, thereby cutting down analysis 
time and offer more information on the relationship between transcriptional and 
translational processes. 
6.2.2 Further investigation on various high and low producers 
In our study, the high producer signature was obtained through the comparison of a 
pair of cell lines producing high and low levels of dhfr-GFP fusion protein. In order to 
generate a common signature for high producers, further investigation on various pairs 
of high and low producer cells producing different products will need to be carried out. 
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6.2.3 Research on unknown genes 
From our microarray data, 41% of the differentially expressed genes had unknown 
functions. Some of these genes could be potentially interesting, and may provide 
additional targets for gene manipulation in host cell engineering. DNA sequences of 
these genes could be screened for possible common motifs/promoters with genes of 
known functions, and their functions could then be proposed with the help of motif 
recognition softwares (e.g. Multiple EM for Motif Elicitation, MEME). 
Furthermore, since only 7559 unique sequences were present on the microarray, 
this means only a fraction of the CHO genome has been screened in our experiments. 
The expansion of the microarray will allow more genes to be screened, and has the 
potential to identify additional processes that are important in the high producer.  
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APPENDIX A: Pearson’s correlation 
The pearson product moment correlation (called pearson correlation for short) is a 
type of distance matrix that checks whether a linear relationship should exist between 
2 arrays of variables.  The computation of the following formula returns a 
dimensionless index (pearson’s correlation coefficient, r) that ranges from –1.0 to 1.0. 
( ) ( )( )









where n = number of paired observations  
X = variable in an array of independent values  
Y = corresponding variable in an allegedly dependent array 
 
A positive coefficient indicates the values of variable A vary in the same 
direction as variable B. A negative coefficient indicates the values of variable A and 
variable B vary in opposite directions. 
Since the comparisons were based on linearity, the input values were log-
transformed, and the results could then be verified by plotting the data on 
scattergrams like the following: 
   
where  r = near 1 represents very high linear correlation  
r = near -1 represents very high linear correlation in the opposite direction 
r = near 0 represents very little correlation between the two arrays
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Carbohydrate Metabolism Dlat 1.14 0.12 0.19 0.04 0.01 0.02  
Carbohydrate Metabolism IDH3A 1.26 0.14 0.33 0.11 0.02 0.05  
Carbohydrate Metabolism LDHA 0.85 -0.13 -0.23 0.05 0.02 0.03  
Carbohydrate Metabolism Pkm2 1.32 0.18 0.40 0.16 0.03 0.07  
Carbohydrate Metabolism Tpi1 0.99 -0.17 -0.01 0.00 0.03 0.00  
  Σ 0.13 0.68 0.36 0.11 0.17 r = 0.90 
Cell Cycle (n=10) 
        
Cell Cycle BCAP31 0.91 -0.35 -0.14 0.02 0.13 0.05  
Cell Cycle Cycs 1.06 -0.12 0.09 0.01 0.01 -0.01  
Cell Cycle Ddx3x 1.04 0.07 0.06 0.00 0.00 0.00  
Cell Cycle DDX5 1.07 0.18 0.10 0.01 0.03 0.02  
Cell Cycle Lrpap1 0.81 -0.24 -0.31 0.09 0.06 0.08  
Cell Cycle Pdcd8 0.85 -0.12 -0.23 0.05 0.01 0.03  
Cell Cycle Tkt 0.83 0.18 -0.27 0.07 0.03 -0.05  
Cell Cycle YWHAB 1.17 0.31 0.22 0.05 0.10 0.07  
Cell Cycle YWHAE 1.17 0.29 0.22 0.05 0.09 0.07  
Cell Cycle YWHAZ 1.12 -0.08 0.16 0.03 0.01 -0.01  
  Σ 0.11 -0.09 0.39 0.47 0.24 r = 0.56 
Cytoskeleton (n=5) 
        
Cytoskeleton Anxa2 1.72 0.42 0.78 0.61 0.18 0.33  
Cytoskeleton Ckap4 0.94 0.38 -0.09 0.01 0.15 -0.03  
Cytoskeleton Rdx 1.03 0.20 0.04 0.00 0.04 0.01  
Cytoskeleton Vim 0.72 -0.16 -0.47 0.22 0.03 0.08  
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Cytoskeleton TPM4 1.08 -0.13 0.11 0.01 0.02 -0.01  
  Σ 0.72 0.37 0.86 0.41 0.36 r = 0.62 
Protein Metabolism (n=16) 
        
Protein biosynthesis RPL15 0.94 -0.18 -0.10 0.01 0.03 0.02  
Protein biosynthesis Rpl18 0.89 -0.23 -0.18 0.03 0.05 0.04  
Protein biosynthesis RPL24 0.69 -0.13 -0.54 0.29 0.02 0.07  
Protein biosynthesis RPL4 0.97 0.48 -0.04 0.00 0.23 -0.02  
Protein biosynthesis RPL5 0.95 0.21 -0.08 0.01 0.05 -0.02  
Protein biosynthesis Rplp2 0.93 -0.08 -0.10 0.01 0.01 0.01  
Protein biosynthesis RPS13 0.94 0.17 -0.09 0.01 0.03 -0.02  
Protein biosynthesis RPS15A 0.95 -0.13 -0.07 0.00 0.02 0.01  
Protein folding Cct4 1.20 0.21 0.27 0.07 0.04 0.06  
Protein folding Serpinh1 1.17 -0.11 0.22 0.05 0.01 -0.02  
Protein folding NPM1 1.09 0.31 0.12 0.02 0.10 0.04  
Protein Modification Rpn2 1.15 0.16 0.20 0.04 0.03 0.03  
Protein Translation Eef1a1 1.56 0.64 0.64 0.41 0.41 0.41  
Protein Translation Eef1d 1.21 0.16 0.27 0.08 0.03 0.04  
Protein Ubiquitylation Nedd4 1.91 0.89 0.93 0.87 0.79 0.83  
Protein Ubiquitylation UBE2L3 0.93 -0.24 -0.11 0.01 0.06 0.03  
  Σ 2.15 1.36 1.90 1.90 1.51 r = 0.78 
Stress Response (n=6) 
        
Response to ER stress HSPA5 0.82 -0.40 -0.29 0.09 0.16 0.12  
Response to ER stress Hspa9a 1.03 -0.21 0.05 0.00 0.05 -0.01  
Response to ER stress HSPCB 1.00 0.25 -0.01 0.00 0.06 0.00  
Response to oxidative stress Cat 1.00 -0.24 0.00 0.00 0.06 0.00  
Response to oxidative stress Gstm1 0.70 -0.33 -0.52 0.27 0.11 0.17  
Response to oxidative stress Mgst1 0.55 -0.51 -0.87 0.76 0.26 0.44  
  Σ -1.44 -1.64 1.11 0.69 0.71 r = 0.67 
Signal Transduction (n=5) 
        
Signal Transduction Anxa1 1.37 -0.04 0.45 0.20 0.00 -0.02  
Signal Transduction RAN 1.22 0.10 0.29 0.08 0.01 0.03  
Signal Transduction RAP1A 1.00 -0.16 0.00 0.00 0.02 0.00  
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Signal Transduction RAP1B 0.97 -0.11 -0.05 0.00 0.01 0.01  
Signal Transduction Txnrd1 1.25 -0.26 0.32 0.11 0.07 -0.08  
  Σ -0.47 1.02 0.40 0.12 -0.07 r = 0.23 
Transcription (n=8) 
        
Transcription Basp1 0.70 -0.45 -0.51 0.26 0.20 0.23  
Transcription Cnbp1 1.00 0.15 0.00 0.00 0.02 0.00  
Transcription H2afy 0.74 0.07 -0.43 0.19 0.00 -0.03  
Transcription HNRPA3 1.12 -0.21 0.17 0.03 0.05 -0.04  
Transcription HNRPU 1.04 0.24 0.05 0.00 0.06 0.01  
Transcription Prpf8 1.18 -0.20 0.24 0.06 0.04 -0.05  
Transcription SMARCA5 1.13 0.15 0.17 0.03 0.02 0.03  
Transcription SYNCRIP 0.94 0.14 -0.09 0.01 0.02 -0.01  
  Σ -0.11 -0.40 0.57 0.41 0.14 r = 0.29 
Transport (n=7) 
        
Transport Atp2a2 1.05 -0.17 0.07 0.00 0.03 -0.01  
Transport Atp5a1 0.93 -0.10 -0.11 0.01 0.01 0.01  
Transport Cox6b1 0.85 -0.17 -0.23 0.05 0.03 0.04  
Transport KPNB1 1.05 0.13 0.07 0.00 0.02 0.01  
Transport Slc25a3 0.91 0.24 -0.14 0.02 0.06 -0.03  
Transport TOMM70A 0.99 0.39 -0.01 0.00 0.15 -0.01  
Transport XPO1 0.91 0.27 -0.14 0.02 0.07 -0.04  
  Σ 0.59 -0.50 0.11 0.37 -0.03 r = 0.07 
Unknown 
        
Unknown Calu 1.37207462 -0.24 0.46 0.21 0.06 -0.11  
Unknown Hdlbp 1.51 0.15 0.59 0.35 0.02 0.09  
Unknown MESDC2 1.83 -0.30 0.87 0.76 0.09 -0.26  
Unknown SH3BGRL 1.10 0.12 0.13 0.02 0.01 0.02  
  Σ -0.28 2.05 1.34 0.18 -0.27  
         
Overall correlation 
 Σ 1.39 1.58 7.04 4.91 2.77 r = 0.47 
 
